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Abstract 
Satisfactory development of preantral follicles from humans and domestic ruminants 
in vitro remains elusive. The aims of this thesis were to use a serum-free culture 
system to identify regulators of early follicle and oocyte development. Preliminary 
experiments determined that bovine preantral follicles grow and produce increasing 
amounts of oestradiol throughout a six day culture period. Neither FSH nor IGF-1 
significantly increased follicle diameter. However, FSH did promote follicular 
oestradiol secretion. The dissociation of follicular growth from steroidogenenic 
function indicated that measurement of follicular diameter may not be a reliable 
marker of physiological follicular development in vitro. In addition, stimulation of 
granulosa cells by FSH may result in inappropriate differentiation of these cells 
during the early stages of folliculogenesis. 
During follicular development, turnover and reconstruction of the basement 
membrane is facilitated and regulated by matrix metalloproteinases (MMPs) and 
tissue inhibitors of metalloproteinases (TIMPs). When MMP-9 was secreted by 
preantral follicles in vitro, the probability of follicles having healthy granulosa or 
theca cells at the end of culture was 0.85 and 0.60, respectively. If TIMP-1 was 
released, there was a probability of 0.79 that the follicles would have healthy somatic 
cells. When TIMP-2 was detected, the probability of granulosa and theca cell health 
was 0.78 and 0.67, respectively. These results indicate that MMP-9 and TIMPs are 
related to follicular health, and can therefore be used as markers of follicular 
development. 
Ascorbic acid has been implicated in several processes associated with 
follicular development, including collagen biosynthesis, steroidogenesis and 
apoptosis. The effect of this vitamin on the development of bovine preantral follicles 
was investigated during a twelve day culture period. Ascorbic acid had no effect on 
follicular growth or oestradiol secretion. Serum addition from Day 0 stimulated 
follicular growth but compromised follicular integrity. By Day 12 of culture, a higher 
proportion of follicles remained intact in the presence of ascorbic acid in serum-free 
conditions, with significantly less granulosa and theca cell death than control 
follicles. Moreover, ascorbic acid significantly increased production of MMP-9, an 
enzyme involved in basement membrane remodelling and a marker for follicular 
health. Therefore, this culture system is capable of supporting follicle growth and 
differentiation over 12 days. Furthermore, ascorbic acid maintains bovine follicular 
health and remodelling in vitro. 
Although IGF- 1 did not increase follicular growth and oestradiol secretion in 
vitro, this factor did stimulate granulosa cell proliferation in preantral follicles during 
a six day culture. However, LR3 IGF- 1, which does not bind to IGF binding proteins, 
was found to have a damaging effect on oocyte development, whereas recombinant 
IGF- 1 promoted oocyte growth in vitro. These experiments highlight the importance 
of the IGF system in the early stages of follicular development, and emphasise the 
need for preserving physiological control mechanisms during follicle culture. 
As well as adding to our understanding of the complex processes involved in 
follicular development, this research has led to the improvement of culture 
conditions for bovine preantral follicles and has identified markers of follicular 
health in vitro. A technique for obtaining a source of homogeneous mature oocytes 
from bovine ovaries would provide a model for in vitro maturation (IVM) and 
fertilisation (IVF) systems for human oocytes, as well as facilitating investigations 
into postovulatory and embryonic development. 
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1.1. Follicular Development 
1.1.1. Primordial Follicles 
Mammalian ovaries develop as two swellings, termed genital ridges, along the ventral 
side of the mesenephros. Primordial germ cells migrate from the yolk sac to the 
genital ridge, and proliferate by mitosis. These germ cells are referred to as oogonia 
once they become enclosed into sex cords located in the cortex of the female gonad. 
This occurs from day 30 of gestation in the cow (reviews: Van den Hurk etal., 1997, 
2000). 
In mammals, mitosis of germ cells is generally completed before birth. During the 
mitotic period, the number of germ cells in bovine ovaries reaches approximately 2 
million; however, the vast majority (90-99%) of these degenerate by the time the calf 
is born, and less than 1% of the non-degenerated oocytes will proceed to ovulation 
(Erickson, 1966). On completion of mitosis, oogonia enter meiosis, and are referred 
to as primary oocytes. During the first meiotic prophase the primary oocytes become 
surrounded by clusters of flattened somatic cells, or pre-granulosa cells that secrete a 
basal lamina thus forming primordial follicles. At the diplotene stage of the first 
meiotic prophase, meiosis is arrested (review: Van den Hurk et al., 1997). 
1.1.2. Initiation of Follicular Growth 
Once the pool of primordial follicles has been established, and in response to an as yet 
unknown signal, follicles are gradually and continuously recruited to grow. This initial 
growth is independent of the pituitary gonadotrophins, follicle stimulating hormone 
(FSH) and luteinising hormone (LH) (Peters el al., 1973). The avascular nature of the 
area in the ovary surrounding the primordial follicles indicates that locally produced 




1.1.3. Follicle Proliferation and Differentiation 
During the follicular growth period, the oocyte grows and the granulosa cells 
proliferate to form a multilaminar structure called a preantral follicle (Figure 1.1). 
During preantral development, the oocyte enlarges and the zona pellucida forms 
around the oocyte. The granulosa cells change from a flattened to a cuboidal shape at 
this time, and are the site of rapid synthesis of matrix components, including basal 
laminae (Rodgers et al., 1998). Connective tissue fibres are arranged parallel to the 
follicular basement membrane, and subsequently hormone-producing large epithelial 
cells and a capillary network constitute the thecal layer (review: Van den Hurk et al., 
1997). Thecal cells differentiate during the course of follicular growth and play an 
integrated role with the granulosa cells in producing oestrogen, as well as secreting 
androgens and a number of growth factors. 
Once the follicle reaches a species-specific size, it forms a fluid filled space called 
an antrum (Figure 1.1). At this stage, follicles become increasingly dependent on 
gonadotrophins for further growth and development. The mature follicle is thus a 
developmental unit with three cell types and two functions; the production of 
hormones and the female gamete (Richards et al., 1995). 
(B) Antrum Formation (150-250 pm) 
FSH 
Preantral Follicle 
(C) Antral Growth (0.2- >8.5 mm) 
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	 Preovulaiorv Follicle 
Figure 1.1. Follicular development. Follicle diameters (shown in brackets) from 
Lussier ci al. (1994). 
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1.1.4. Oocyte Development and Maturation 
Growing oocytes from immature follicles are not capable of resuming meiosis and are 
said to be meiotically incompetent. In rodents, it is generally accepted that oocytes 
stop growing and attain meiotic competence at approximately the time of antrum 
formation (Iwamatsu and Yanagimachi, 1975). However, in other species, the 
relationship between antrum formation, meiotic competence, and cessation of oocyte 
growth is not as well understood. 
Using follicle size as an indicator of the competence of the oocytes they 
contain, oocytes from antral follicles larger than about 2 mm in diameter are thought 
to be fully grown and can resume meiosis spontaneously (cows and pigs: Motlik and 
Fulka, 1986). In these species, however, meiotic competence is acquired in two steps, 
based on the demonstration that pig and cow oocytes of 100 .jm in diameter can 
resume meiosis but do not progress beyond Metaphase I, whereas cow oocytes of 110 
im and pig oocytes of 115 tm diameter complete meiotic maturation-to Metaphase II 
(Fair et al., 1995; Hyttel etal., 1997; Motlik and Fulka, 1986). Hence oocyte size, 
rather than follicle size, is a more accurate indicator of meiotic competence. 
It has been suggested that oocytes may have an autonomous chronological 
programme for acquisition of meiotic competence (Harada etal., 1997). There may 
also be external stimulation by companion somatic cells in order for oocytes to 
become fully competent with a timing equivalent to that found in vivo. Harada and 
colleagues (1997) implicated the participation of FSH and hypoxanthine in the 
acquisistion of meiotic competence in growing bovine oocytes in vitro. 
1.1.5. Follicular Oestrogen Synthesis 
The ovary is the principal site of oestrogen production in the female (review: Zeleznik 
and Hillier, 1996). The principal oestrogen, oestradiol 170 (E 2), functions in the 
selection of follicles for ovulation during the reproductive cycle. The onset of 
follicular oestradiol secretion reflects a functional interplay between the two major 
steroidogenic cell types within the follicle (granulosa and theca) regulated by FSH and 
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LH. As illustrated in Figure 1.2, LH stimulates precursor androgen synthesis in the 
theca and FSH stimulates granulosa cell aromatase activity (Armstrong et al., 1979). 
Thus both cell types and both gonadotrophins are thought to be necessary for 
oestrogen synthesis (Armstrong et al., 1979; Hillier etal., 1994) 
1.1.5.1. Thecal androgen synthesis 
Blood-borne cholesterol and acetate are converted into androgens within the 
vascularised theca interna, in which cytochrome P450 (P450 17), the rate limiting 
enzyme in androgen synthesis (Sasano etal., 1989), is abundantly expressed. This 
process is positively regulated by LH during antral development (Erickson et al., 
1985). IGF-1 and insulin receptors functionally coupled to androgen synthesis are also 
present on theca cells (Bergh et al., 1991), and in vitro experiments have 
demonstrated that IGF- 1 can enhance both basal and LH stimulated androgen 
production (Cara and Rosenfield, 1988; Hillier etal., 1991). 
1.1.5.2. Granulosa cell oestrogen synthesis 
The avascular granulosa cells are exposed to androgens by diffusion from the theca 
interna. Once in the mural granulosa cell layer, androgens are converted into 
oestrogens through the action of aromatase (P450 arom), which is under FSH control 
(review: Zeleznik and Hillier, 1996). IGF-1 has also been shown to be capable of 
stimulating oestradiol and progesterone production in cultured human granulosa cells 
in a dose-dependent manner (Zhao etal., 1998). In addition, both insulin and IGF-1 
enhance basal progesterone and cAMP in cultured porcine granulosa cells (Sekar el 
al., 2000), and stimulate oestradiol secretion and P450arom mRNA in cultured bovine 
granulosa cells (Manuel Silva and Price, 2000). The '2-cell, 2-gonadotrophin' 











Figure 1.2. The 12-cell, 2-gonadotrophin' model of follicular oestrogen 
biosynthesis. Androgen synthesis, regulated by LH, occurs in the theca interna, 
catalysed by P450c17. Andogens are converted to oestrogens in the granulosa cells 
by P450arom in response to FSH. Adapted from Zeleznik and Hillier (1996). 
1.1.6. Follicular Atresia 
Less than 1% of follicles in the developing ovary will proceed to ovulation, whilst the 
rest will degenerate by a process called atresia (Erickson, 1966). This ensures that the 
correct number of oocytes reach maturity and are ovulated in each cycle. It is thought 
that atresia occurs through an apoptotic mechanism (Hughes and Gorospe, 1991; 
Tilly el al., 1991), which, as originally defined by Kerr ci al. (1972), is the best 
characterised form of physiological or programmed cell death. 
Morphologically, apoptosis is recognised by detachment of a cell from its 
neighbours, cytoplasmic collapse and cell shrinkage (anoikis), condensation of 
chromatin and its redistribution to the nuclear perimeter (pyknosis), and the budding 
of spherical pieces of plasma membrane referred to as apoptotic bodies (Kerr el at, 
1972, 1994; Majno and Joris, 1995; Zakeri el al., 1995, review: Martimbeau and 
Tilly, 1997). The main feature which distinguishes apoptotic cell death from necrotic 
cell death is the regulated action of Ca 2'/Me dependent endonucleases which cleave 
Chapter 1 
the internucleosomal linker DNA of the nucleus into multiples of 185-200 base pairs 
(review: Martimbeau and Tilly, 1997). These DNA fragments can be detected using 
end labelling and separation by agarose gel elecrophoresis producing a characteristic 
laddering pattern (Wyllie, 1980). In addition, terminal deoxy nucleotidyl tranferase-
mediated dUTP-biotin nick end labelling (TUNEL) utilises the activity of terminal 
deoxynucleotidyl transferase (TdT) enzyme to incorporate biotinylated dUTP onto 
the 3' ends of fragmented DNA (Gavrieli et al., 1992). 
Several factors have been identified which induce or suppress apoptosis (Tilly 
etal., 1992; Billig etal., 1993, 1994; Chun etal., 1994). Anti-apoptotic factors 
include gonadotrophins, growth factors (e.g. EGF, TGFa, bFGF and IGF-1) and 
oestrogens. Factors which induce apoptosis include androgens and GnRH. 
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1.2. Investigation of Follicular Development 
1.2.1. In vivo Studies 
On the basis of gross and histological study of ovaries, it was proposed in 1960 that 
two waves of follicular activity occurred during the bovine oestrus cycles (Rajakoski, 
1960). The wave pattern of follicular development refers to periodic, synchronous 
growth of a group of antral follicles. More recently, it has been shown that greater 
than 95% of bovine oestrus cycles are composed of either two or three follicular 
waves (Savio etal., 1988; Sirois and Fortune, 1988; Ginther etal., 1989; Adams el 
al., 1994). Ultrasound tracking studies have proved useful in clarifying the number of 
waves per cycle as well as characterising the composition of follicular waves (Ginther 
etal., 1989). However, this technique has not been successfully applied to detection 
of changes in preantral or early antral follicles during development. 
Hormone treatment followed by ovariectomy, or techniques such as 
hypophysectomy have been useful for studying the function of gonadotrophins during 
early follicular development (e.g. Chiras and Greenwald, 1978; Nakano et al., 1975). 
However, these experiments have limitations in terms of tracking follicular 
development over time. 
In order to understand the complex mechanisms regulating folliculogenesis, it 
is useful to study natural or induced mutations that influence these processes. 
Transgenic mouse models have proved to be powerful tools for identification of key 
factors required for normal folliculogenesis (Matzuk, 2000). However, this technique 
cannot be readily applied to domestic ruminants. There is evidence of several major 
genes affecting prolificacy in sheep (Davis et al., 2001), and these have provided a 
valuable model for the study of follicular growth and selection in large mammals. For 
example, the Booroola phenotype of increased litter size was originally selected in 
specific lines of Australian Merino sheep. Subsequent studies of sheep carrying the 
Booroola gene (FecB) confirmed segregation as a single autosomal locus (Davis et 
al., 1982; Piper and Bindon, 1982). Ovarian follicles in Booroola Merinos, carrying 
the FecB gene, mature and ovulate at a smaller diameter than non-carriers of the 
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mutation (Webb et al., 1999). Recently, Booroola sheep were shown to possess a 
mutation in the bone morphogenetic protein lB (BMW 113) receptor (ALK-6) that is 
expressed in both oocytes and granulosa cells (Shimasaki etal., 1999). BMPs are 
members of the transforming growth factor-f' (TGF-3) superfamily, which are 
multifunctional proteins that regulate growth and differentiation in many cell types. 
Another major gene (FecX) affecting ovulation rate has been found in Romney sheep 
(Davis etal., 1991). The Inverdale fecundity gene (FecX), which maps to the sheep X 
chromosome, carries an inactivating mutation in growth/differentiation factor-9b 
(GDF-9bIBMP-15) (Galloway etal., 2000), which is an oocyte specific factor (Dube 
et al., 1998). Hence mutations in the BMP signalling system may contribute to the 
increased ovulation rate observed in Booroola and Inverdale animals. Interestingly, 
ewes that are homozygous for inactivation of GDF-9bIBMP- 15 (Inverdale) are 
infertile due to a block in follicular growth, and those that are heterozygous for the 
mutation have increased ovulation rates (Galloway et al., 2000). These findings 
establish that BMIPs are important for female fertility and that natural mutations in an 
ovary-derived factor can cause both increased ovulation rate and infertility phenotypes 
in a dose-sensitive manner (Galloway et al., 2000). 
1.2.2. In vitro Studies 
Normal folliculogenesis resulting in an oocyte capable of fertilisation and embryonic 
development depends upon a complex sequence of cellular interactions within the 
follicle. These create a. unique and progressively shifting environment for the 
development of the oocyte. At any stage during this development, the follicle may 
continue normally or, more frequently, proceed towards atresia. To study the 
mechanisms involved, it is necessary to follow and influence the development of 
individual follicles in vitro. 
Culture systems for preantral follicles, or their oocyte-granulosa cell 
complexes, are important for studying oocyte development, but are also vital for 
analysis of follicular somatic cell development and function. Growth of follicles in 
culture allows each follicle to be studied continuously and makes it possible to relate 
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particular developmental characteristics to subsequent reproductive performance of 
the gamete, thereby defining normal follicular development more accurately. 
1.2.2.1. Rodent follicle culture systems 
For successful oocyte growth in vitro, it is important to maintain the three-
dimensional organisation of the granulosa cells and oocyte-somatic cell contact 
(Eppig, 1991). Therefore, culture systems developed using isolated granulosa cells 
(Gutierrez et al., 1997b), whilst being valuable in determining the effects of growth 
factors and hormones, have limitations. Isolation techniques involving degradation of 
the theca cell layer and the basement membrane by collagenase results in granulosa 
cell-oocyte complexes (GOC), which have been cultured by Eppig and Schroeder 
(1989) to produce oocytes which have grown and have acquired developmental 
competence. As the oocyte itself is key to determining granulosa cell function, and the 
main role of the follicle is to support the development of the oocyte, culture systems 
for intact follicles or oocyte-granulosa cell complexes are preferable as they are more 
comparable to the environment in vivo. 
Nayudu and Osborn (1992) used a manual dissection procedure to retrieve 
individual preantral follicles-from the murine ovary. Because enzymatic digestion was 
not used, this system allowed the culture of preantral follicles with a theca layer and 
intact basement membrane. This was important for the examination of interfollicular 
effects and steroidogenesis. Murine follicle culture has also allowed the study of 
metabolism during folliculogenesis (Boland etal., 1993). 
The viability of the systems outlined above has been demonstrated by the 
production of live offspring from in vitro grown GOCs from murine preantral follicles 
(Eppig and Schroeder 1989) and from the culture of whole preantral follicles (Spears 
etal., 1994). More recently, oocytes from primordial follicles activated in vitro have 
also acquired competence to be matured and fertilised, resulting in the production of a 
live mouse (Eppig and O'Brien, 1996). 
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1. 2.2.2. Bovine follicle culture systems 
As discussed above, techniques have been developed for isolating and culturing 
preantral follicles from a range of rodents and these have produced developmentally 
competent oocytes and viable offspring (Roy and Greenwald, 1989; Torrance et al., 
1989; Eppig and Schroeder, 1989; Spears etal., 1994; Cortvrindt etal., 1996). The 
limited success of these rodent systems has resulted in attempts to develop similar 
methods to be applied in humans (Abir et al., 1997; Wright etal., 1999) and domestic 
species (reviews: Telfer et al., 2000; Van den Hurk et al., 2000). 
For livestock production, the culture of small oocytes could potentially 
provide a large population of female germ cells. Advances have been made in 
transferring aspects of the rodent systems to development of in vitro porcine follicle 
systems (Hirao et al., 1994, Wu etal., 2001). However, less densely packed follicles, 
more fibrous stromal tissue, larger follicles and slow follicular growth have all played 
a role in delaying a successful system for isolation and culture of bovine preantral 
follicles. 
Complete in vitro growth of bovine preantral follicles is ambitious since 
preantral development is lengthy (4-5 months); therefore prolonged culture is 
necessary if developmentally competent oocytes are to be obtained. In addition, as the 
follicles increase in size, problems of nutrient restriction and insufficient gas and waste 
exchange may arise. In previous studies using bovine preantral follicles, culture was 
terminated long before preovulatory stage had been reached (Hulshofet al., 1995; 
Ralph etal., 1995b; Figueiredo etal., 1995; Gutierrez etal., 2000; Saha et al., 2000). 
Nevertheless, preantral follicles from sheep and cattle have recently been grown to the 
antral stage of development in vitro (Cecconi etal., 1999; Gutierrez etal., 2000), 
indicating that follicle differentiation can be achieved under culture conditions. 
However, these follicle culture systems for domestic ruminants have been 
unsuccessful in obtaining oocytes capable of undergoing meiotic maturation. 
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1.3. Factors Affecting Follicular Development 
There is little information on the regulation of primordial activation and subsequent 
preantral growth, with conflicting views on the role of specific factors in follicle 
growth and development. 
1.3.1. Endocrine and Autocrine Regulation 
Granulosa cells are the only cells in the female body to possess FSH receptors, and 
binding ofFSH to the cell surface activates adenylyl cyclase and cyclic AMP-
dependent protein kinase(s) leading to altered expression of multiple genes crucial to 
cytoproliferation and differentiation (review: Zeleznik and Hillier, 1996). Follicles can 
develop from the primordial to the late preantral stage in the complete absence of 
gonadotrophins (Dufour et al., 1979). However, the involvement of FSH in the 
development of small follicles is supported by the presence of binding sites/receptors 
for FSH in granulosa cells of cows (Wandji et al., 1992) and other mammals 
(Monniaux and de Reviers, 1989; Eckery etal., 1997). Furthermore, FSH has been 
reported to activate granulosa cell proliferation and differentiation, and to reduce the 
number of atretic follicles grown in vitro (rodent: Tonetta and diZerega, 1989; Roy 
and Greenwald, 1989; Gore-Langton and Daniel, 1990; Nayudu and Osborn, 1992; 
Spears etal., 1998; cow: Huishofe! al., 1995; Wandji etal., 1996; sheep: Newton et 
al., 1999; human: Roy and Treacy, 1993; Abir et al., 1997). The mitogenic action of 
FSH is facilitated by locally produced growth factors, production and/or action of 
which may be modified by FSH (Zeleznik and Hillier, 1996). 
McNatty et al. (1979) reported that LH was required for oestrogen 
biosynthesis within the follicle (Figure 1.2). In vitro, murine follicles grown to the 
preovulatory stage have been shown to respond to LH by progesterone production 
(Qvist etal., 1990) and ovulation (Boland etal., 1993). Suitable balances between 
FSH and LH during a long term culture may be necessary in order to obtain optimum 
conditions for follicle and oocyte development. 
Oestrogens are well known endocrine and intrafollicular autocrine mitogenic 
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compounds (Tonetta and diZerega, 1989). In cultured pig large preantral follicles, 
oestradiol synergises with FSH to enhance granulosa cell proliferation and antrum 
formation (Hirao etal., 1994). In contrast, oestradiol has not been found to affect the 
proliferative activity of granulosa cells, but does appear to increase the size of bovine 
cultured primary and small secondary follicles (Hulshofet al., 1995). 
1.3.2. Intraovarian Regulation 
1.3.2.1. Ovarian peptides 
There is growing evidence that intraovarian peptides such as growth factors, 
extracellular matrix (ECM) compounds and neuropeptides exert paracrine 
communication within follicles. During preantral follicle development, growth factors 
such as epidermal growth factor (EGF); basic fibroblast-like growth factor (bFGF); 
transforming growth factors (TGFs); vascular epithelial growth factor (VEGF) and 
nerve growth factors (NGFs) may influence folliculogenesis (review: Van den Hurk et 
al., 1997). As will be discussed later, the IGF system may also be a key regulator of 
early folliculogenesis. 
The TGF-13 superfamily is made up of a number of proteins with the potential 
to act as intraovarian regulators of ovarian function (Armstrong and Webb, 1997). 
For example, growth/differentiation factor-9 (GDF-9), a member of the TGF-
superfamily, is an oocyte-derived factor which has been reported to be essential for 
normal follicle development beyond the primary (one granulosa layer) follicle stage in 
mice (Dong et al., 1996). TGF-Os may also play a significant role in folliculogenesis in 
ruminants. For example, as discussed earlier, mutations in the TBF-f3 signalling 
system have been implicated in the increased ovulation rate observed in Booroola and 
Inverdale sheep (Wilson etal., 2001; Galloway etal., 2000). In cattle, TGF43s inhibit 
granulosa and theca cell proliferation while enhancing gonadotrophin-stimulated 
steroidogenesis (Roberts and Skinner, 1991), and bovine theca cells have been shown 
to produce TGF-3 in culture (Lobb and Dorrington, 1992). In addition, it has been 
hypothesised that activin and inhibin, which are disulphide-linked dimeric 
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glycoproteins belonging to the TGF-3 family, play an autocrine/paracrine role in 
controlling early follicular development by promoting follicular growth and 
differentiation (Findlay, 1993; Mather et al., 1997). Intraovarian actions of granulosa 
cell-derived activins include the promotion of granulosa cell proliferation and 
upregulation of FSH receptors, P450arom, oestrogen synthesis, granulosa cell LH 
receptors and enhancement of oocyte maturation (review: Knight and Glister, 2001). 
Recently, it was reported that activin produced by secondary mouse follicles 
suppresses the growth of primary follicles in vitro (Mizunuma etal., 1999), and it was 
hypothesised that a local decline in activin as a result of atresia of secondary follicles 
initiates early folliculogenesis in response to circulating FSH (Mizunuma etal., 1999). 
In addition to an endocrine feedback role, granulosa-derived inhibins can sensitise 
theca cells to LH, thereby enhancing the production of androgens, an essential 
requirement for follicular oestrogen synthesis (Knight and Glister, 2001). The 
auto crine and paracrine actions of inhibin on enhancement of gonadotrophin 
stimulated steroid secretion by ovine and bovine granulosa and theca cells has recently 
been demonstrated (Webb et al., 1999). 
15 
Chapter 1 
1. 3.2. 1.1. Follicular extracellular matrix 
1.3.2.1.1.1. Composition andfunction 
The extracellular matrix (ECM) provides a 'scaffolding' within a tissue to which cells 
attach, and contains domains that bind to specific cell surface receptors to modulate 
cellular activity. For example, ECM proteins interact with integrin receptors; 
transduce cytoplasmic signals; modulate the bioavailability of growth factors; and play 
a role in paracrine regulation of cellular differentiation, proliferation and apoptosis. 
The membrana granulosa of each follicle is enveloped by a follicular basal 
lamina, or basement membrane, which separates it from the surrounding thecal and 
stromal cells (Gosden et al., 1988; Luck, 1994; van Wezel and Rodgers, 1996). Basal 
laminas are composed of networks of collagen IV intertwined with laminin (Rodgers 
etal., 1995). Fibronectin, heparinsulphate proteoglycans (HSPGs) and other 
molecules are associated with the collagen IV-laminin backbone. In vivo, extracellular 
matrix components such as laminin, fibronectin, collagens, and proteoglycans have 
been detected in follicles (Rodgers etal., 1995). In bovine preantral follicles, collagen 
type IV and laminin have been detected in the basement membrane (which separates 
the granulosa and thecal layers), and fibronectin has been immunohistochemically 
visualised around preantral follicles and in granulosa cells (Figueiredo et al., 1995). In 
ovine follicles, Huet and colleagues (1997) reported parallel changes in ECM 
components and steroidogenic enzymes in theca and granulosa cells during growth 
and atresia. For example, follicle growth was characterised by an increase in 
fibronectin and type I collagen in theca interna and granulosa cells respectively. 
Atresia was characterised by increased fibronectin, laminin, and type IV collagen in 
the wall of granulosa cells (Huet et al., 1997). 
Basal laminas in different parts of the body differ in the ratio of their 
components, thus the unique composition of each basal lamina contributes to its 
specific functional properties (Engvall, 1993). The surface area of the bovine follicle 
has been estimated to double nineteen times during folliculogenesis, and different 
isoforms of collagen IV and laminin are present within the follicular basement 
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membrane at different developmental stages (Rodgers et a!, 1998). These 
observations suggest that the follicular basal lamina is continually remodelled during 




The enzymes responsible for degrading the proteinaceous components of the ECM 
are the matrix metalloproteinases (MIMPs). These are zinc and calcium-dependent 
enzymes that include collagenases, gelatinases, stromelysins and the membrane bound 
metalloproteinases (Nagase, 1997). MIvIP activity is highly regulated and subject to 
control at several levels (Kleiner and Stetler-Stevenson, 1993). Two important points 
of regulation include activation of latent enzymes and association with tissue 
inhibitors of metalloproteinases (TIMIPs). To date, 17 members of the MIIvI1P family 
and 4 members of the TRAP family have been identified (Table 1.1 and 1.2). 
Table 1.1. MMP family of ECM proteinases. Adapted from Smith etal. (1999). 
Family 	 Name 	Matrix substrates of functions 
Collagenase MIM1P- 1 Collagens I, II, III, VII, X 
MtvIP-8 	 Collagens I, II, III 
MIVIP- 13 Collagens I, II, III 
MTvIIP- 18 	 Collagen I 
Gelatinases 	MMP-2 Gelatins, collagens IV, V, VII, X, XI, 
fibronectin, laminin 
M1MP-9 	Gelatins, collagens IV, V, XIV, 
fibronectin 
Stromelysins 	Milv1P-3 	Gelatins, fibronectin, laminin, collagens 
III, IV, IX, X, vitronectin: activates 
proMMP-1 
MJvIP- 10 	 Fibronectin, collagen IV 
MTvIP-20 Amelogenin 
Membrane-type MMPs 	MIvIP-14 	Collagens I, II, III, fibronectin, laminin, 
vitronectin: activates proMMP-2 and 
proMMP- 13 
MP"- 15 	Gelatin, fibronectin, laminin: activates 
proMMP-2 
WIMP- 16 	 Activates proMMP-2 
MIMP- 17 Not known 
Others 	 MTvIP-7 	Fibronectin, laminin, gelatins, collagen IV 
MIMP- 11 Weak activity on fibronectin, laminin, 
collagen IV, gelatins 
N"- 12 	 Elastin 
MMP-19 Not known 
Table 1.2. TIMP family. Adapted from Mclntush and Smith (1998). 
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Inhibitor 	Relative molecular weight 	Extracellular location 
TIMP-1 28 000 	 Soluble in ECM and body fluids 
TIIvIP-2 	 21 000 Soluble in ECM and body fluids 
TIMP-3 24 000 	 Bound to ECM 
TIMP-4 	 22 000 Not known 
Evidence is emerging that MMPs and TIMPs not only remodel the extracellular 
matrix but also influence many cellular functions. For example, TEMP-1 is a 
multifunctional molecule that stimulates proliferation of various cell types (Edwards et 
al., 1996) and promotes steroiodogenesis (Boujrad etal., 1995). In addition, as 
discussed previously, interactions between ECM components and cell surface 
molecules regulate cell behaviour. In a changing environment, the ability of cells to 
proliferate, survive or differentiate also changes. Therefore, MIVIPs can alter cell 
behaviour through their action on the ECM. 
Follicular development requires significant proliferation of granulosa and 
thecal cells. The role of growth factors in control of cell proliferation has been studied 
extensively. Many growth factors are secreted constitutively and sequestered in the 
ECM in an inactive form or in association with specific binding proteins where they 
can be subsequently liberated by proteolysis of the ECM (Logan and Hill, 1992). 
Therefore, MMPs may play a key role in the regulation of the availability of growth 
factors and their activities within developing follicles. 
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1. 3.2.1.2. Insulin-like growth factor system 
Insulin has been shown to have a dose-dependent stimulatory effect on granulosa cell 
proliferation (Saumande, 1991; Langhout etal., 1991; Peluso el al., 1995). Similarly, 
insulin-like growth factors (IGFs), and particularly IGF- 1, have been identified as 
important paracrine regulators of ovarian function. IGF-1 has been shown to be an 
absolute requirement for normal ovarian function, as mice in which IGF- I gene 
expression was disrupted showed reduction in ovarian weight and failed to ovulate 
(Baker etal., 1996). 
Within bovine antral follicles, there is evidence of a complete intrafollicular 
IGF system (Armstrong et al., 1998, 2000) in which follicles express IGF ligand, and 
mediation of IGF action and bioavailability occurs through receptors and binding 
proteins. As illustrated in Figure 1. 3, the expression of mRNA encoding IGF-1 is 
developmentally regulated in a species-specific manner (Armstrong and Webb, 1997; 
Webb and Armstrong, 1998). Low levels of IGF-1 mRNA have been detected in 
theca cells of bovine antral follicles (Armstrong et al., 2000), whereas in rodents and 
pigs, IGF-1 mRNA has been reported to be expressed by granulosa cells (Oliver et 
al., 1989; Zhou etal., 1996). In ruminants, various studies have demonstrated both 
the presence (Spicer et al., 1993; Leeuwenberg etal., 1995; Spicer and Echternkamp 
1995; Yuan etal., 1996) and absence (Perks etal., 1995, 1999; Armstrong etal., 
1998,2000) of IGF-1 mRNA in granulosa cells (Figure 1.3). Moreover, IGF-1 has 
not been found to be produced by ovine or bovine granulosa cells in vitro in the 
absence of luteinisation (Wathes etal., 1995; Gutierrez etal., 1997a; Armstrong et 
al., 2000). 
Investigations into the expression of IGFs within bovine follicles have 
indicated that IGF-1 1 is the predominant IGF in vivo (Armstrong etal., 2000). 
However, type I IGF receptor expression has been demonstrated in follicles at an 
earlier stage than IGF-1 1 m.RNA has been detected. Therefore, it has been 
hypothesised that preantral follicles may be regulated in vivo by IGFs from the 
circulation (Armstrong etal., 2000). IGF-1 1 mRNA is expressed in theca cells of 
bovine follicles at around the time of antrum formation (Armstrong et al., 2000) 
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(Figure 1. 3), and the timing of expression of IGF- 11 correlates with acquisition of LH 
receptors in the théca cells. Since IGF-1 has been shown to increase LH receptor 
number in bovine theca cells (Stewart etal., 1995), it can be speculated that in vivo, 
IGF- 11 takes the place of IGF- 1 and regulates the timing of onset of LH receptor 
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Figure 1.3. Follicular IGF expression 
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Previous studies have helped to determine the actions of IGFs in antral follicles, which 
are thought to vary according to species and the interaction of gonadotrophins 
(Giudice, 1992). For example, granulosa cells from bovine antral follicles show 
increased proliferation and oestradiol production in response to IGF- I (Gutierrez et 
al., 1997b). IGF-1 has also been shown to stimulate proliferation and oestradiol 
secretion in the absence of FSH (Adashi and Roban, 1992). Although the precise role 
of the IGF system at earlier stages of follicle development is poorly understood, IGF - 
1 binding has been demonstrated in bovine preantral follicles (Wandji et al., 1992) and 
type 1 IGF receptor mRNA has been detected in bovine oocytes, granulosa and theca 
cells from the preantral stage (Armstrong et al., 2000). 
The bioactivity of IGFs is controlled by their association with a family of 
specific IGF binding proteins (IGFBPs), which are found in association with the 
extracellular matrix (ECM) and cell membranes. To date, expression of mRNAs 
encoding IGFBP-2 to —5 have been found in bovine follicles and expression of 
IGFBP-2, -4 and —5 in ovine follicles (Armstrong and Webb, 1997; Webb and 
Armstrong, 1998). IGFBP-2 and —4 mRNA expression in non-atretic bovine follicles 
is confined to granulosa and theca tissue, respectively (Armstrong et al., 1998). 
During follicular development and atresia, there are distinct changes in the temporal 
and spatial expression of these proteins in vivo. For example, during the development 
of follicular dominance, intrafollicular amounts of IGFBP-2, -4 and —5 are decreased, 
whereas during atresia, the levels of these proteins increase (Austin et al., 2001). Thus 
changes in the expression of IGFBPs, coupled with changes in the activity of IGFBP-
specific proteases, provide a mechanism to regulate the bioavailability of IGFs during 
folliculogenesis (Armstrong etal., 1998). Since IGFBPs have equal or higher affinity 
for IGFs than do IGF receptors (Shimasaki et al., 1991), the degradation of IGFBPs 
by specific IGFBP-degrading proteinases may be an important step in regulating the 








Figure 1.4. Mechanism of IGF action. IGFs are stored in extracellular depots in 
association with binding molecules (IGFBP5). IGFs can be liberated and functionally 
activated by the action of IGFBP-specific proteases which partially degrade IGFBPs 
resulting in a reduced affinity for the ligand versus that of the tissue receptors, or by 




1.3.2.2. Oocyte-spec jfic factors 
The three dimensional organisation of the cells and the interactions of the various 
follicular cell types is critical for normal cell development and function. It is becoming 
increasingly apparent that the oocyte plays a crucial role in somatic cell development 
and function, as well as vice versa (Buccione etal., 1990; Vanderhyden etal., 1990, 
1992). Studies regarding the molecular aspects of follicle and oocyte development are 
still very much at a primary stage. Preliminary characterisation of the cumulus 
expansion enabling factor in mouse oocytes (Eppig etal., 1993) has been instrumental 
in gaining knowledge of the interactions between the oocyte and surrounding somatic 
cells, but the mechanisms governing oocyte-specific gene expression are still 
unknown. The enabling factor has been detected in bovine oocytes, but is not essential 
for cumulus expansion (Ralph etal., 1995a), which suggests either a different 
function or a different mode of action for the secreted factor in this species. 
Growth/differentiation factor-9 (GDF-9), a member of the TGF-13 superfamily, 
is an oocyte-derived factor which has been reported to be essential for normal follicle 
development beyond the primary (one granulosa layer) follicle stage in mice (Dong el 
al., 1996). This novel growth factor has been shown to be expressed in human and 
mouse ovaries, and appears to be localised exclusively to oocytes at all stages of 
follicular growth except primordial follicles in neonatal and adult mice (McGrath et 
al., 1995). The pattern of GDF-9 expression and results from GDF-9 gene knockout 
studies in mice suggest that this factor may play an autocrine role in the regulation of 
oocyte development and maturation and/or a paracrine role in the regulation of 
granulosa cell proliferation and differentiation. Mouse studies (Dong et al., 1996; 
Elvin etal., 1999) have also shown that in the absence of GDF-9, follicles are 
incompetent to emit a signal that recruits theca cell precursors to surround the 
basement membrane (Elvin etal., 1999). Recently, the expression of GDF-9 mRNA 
has also been demonstrated in bovine and ovine oocytes from the primordial follicle 
stage (Bodensteiner et al., 1999). An oocyte-specific homologue of GDF 79, named 
BMIP-15 (GDF-9b) has also been cloned in mice (Dube etal., 1998). As discussed 
previously, the Inverdale fecundity gene (FecX) carries an inactivating mutation in 
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BMW-15 (Galloway et al., 2000), implicating this factor in the control of ovulation 
rate in sheep. 
The tyrosine kinase receptor c-kit and its ligand, stem cell factor (SCF), have 
been localised to oocytes and granulosa cells, respectively (Motro and Bernstein, 
1993). Inhibition of the interaction between SCF and c-kit prevents the transformation 
of murine primordial follicles to primary follicles (Huang etal., 1993; Yoshida etal., 
1997). In the sheep ovary, c-kit and SCF have been detected at all stages of follicular 
growth from the primordial phase (Clark et al., 1996; Tisdall etal., 1997). Thus the 
activation of the c-kit tyrosine kinase system by SCF appears to be an important 
process during early folliculogenesis. 
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1.4. The Role of Ascorbic Acid in Follicular Development 
Ascorbic acid, or vitamin C, is synthesised from glucose in the liver of most mammals. 
However, primates, fruit eating bats and guinea pigs require a dietary intake of 
ascorbic acid, as they lack L-gulono-lactone oxidase, one of the enzymes necessary 
for its synthesis (Grollman and Lehninger, 1957). The critical functions of ascorbic 
acid in biological systems derive from its ability to donate electrons while itself 
undergoing reversible oxidation (Bielski et al., 1975). This principle is illustrated in 
Figure 1.5. 
R.+Asc 	0,'R+AFR 
/-e \e, +IH-+ 
Diketogulonic 4 	IIAA DHAA-Reductase  Asc 
Acid 
Figure 1.5. Mechanism of ascorbic acid action. A possible scheme by which 
a free radical species (R.) is neutralised by single electron transfer with ascorbic acid 
(Asc). This results in a detoxified product (R) and the ascorbyl free radical (AFR). 
Pairs of AFR disproportionate to form one molecule of dehydro-L-ascorbic acid 
(DHAA) and one Asc. DHAA can undergo a biologically irreversible opening of the 
lactone ring to form the inert product, diketo-L-gulonic acid; alternatively, it can be 
reduced to the useful Asc. From Rose and Bode (1993). 
27 
Chapter 1 
There are three biological actions of ascorbic acid which are relevant to reproduction. 
It is required for the biosynthesis of collagen, for the biosynthesis of steroid and 
peptide hormones and to prevent or reduce the oxidation of biomolecules (review: 
Luck et al., 1995). 
An example of the effect of ascorbic acid on connective tissue biosynthesis 
was presented by Jeffrey and Martin (1966), who showed a marked increase in the in 
vitro growth of embryonic chick bones in the presence of ascorbic acid, compared to 
bones grown in media without ascorbic acid. Acting as an electron donor, ascorbic 
acid is an essential co-factor for the enzymes that hydroxylate proline and lysine 
residues during the post-translational processing of pro-collagen (Pinnell, 1985). As 
these enzymes are necessary for collagen helix formation and cross-linking, in the 
absence of ascorbic acid, collagen would be structurally unstable and would not be 
properly secreted by the cell (Pinnell, 1985). In addition to its role as an enymatic co-
factor, ascorbic acid has also been reported to stimulate collagen-specific mRNA in 
fibroblasts (Pinnell, 1985). 
The ovarian content of ascorbic acid changes throughout the oestrus 
cycle. Prior to ovulation, ascorbic acid levels decline followed by an immediate rise in 
concentration, which facilitates progesterone production, consistent with the role of 
ascorbic acid in steroidogenesis (Byrd et al., 1993). It has also been suggested that 
ascorbic acid at high concentrations inhibits steroidogenesis (Sanyal and Datta, 1979). 
The effects of this factor on hormone production during the early stages of 
folliculogenesis have not been elucidated. 
The role of ascorbic acid as a free radical scavenger is well understood. Using 
cultured follicles, Tilly and Tilly (1995) reported that inhibitors of oxidative stress 
such as superoxide dismutase, ascorbic acid and catalase, can mimic the ability of FSH 
to prevent apoptosis in vitro. Moreover, recent investigations have shown that FSH 
and IGF- 1, both of which are anti-apoptotic in granulosa cells (Chun et al., 1994; 
Tilly and Tilly, 1995), increase ascorbic acid uptake by granulosa cells through 
activation of a membrane-associated ascorbate pump (Behrman et al., 1996). Since 
follicles acquire responsiveness to gonadotrophins and grow rapidly during the late 
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preantral stages of follicle development, the ability to accumulate ascorbic acid may 
promote follicle survival. 
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1.5. Aims of Research 
The aims of this thesis are: 
To investigate factors affecting early bovine follicular development using a 
defined culture system. 
To identify markers of early follicular development in vitro. 
A limiting factor in reproductive methods such as IVF, embryo transfer, transgenesis 
and cloning is the lack of available fertilisable oocytes. Techniques such as 
superovulation can increase the number of oocytes ovulated by an individual, but this 
technology has limitations, as oocytes cannot be harvested from the large population 
of hormone-insensitive preantral follicles. Methods for in vitro maturation (IVM) of 
oocytes from antral follicles have been developed. However, the success rate and 
quality of embryos produced by IVM is low (reviews: Telfer et al., 2000; Van den 
Hurk etal., 2000). This may be explained by Telfer eta! (1998a), who showed that 
90% of antral follicles were undergoing apoptotic cell death at the time of isolation. In 
contrast, only 10% of preantral and early antral follicles showed any sign of apoptosis 
(Telfer etal., 1998a). Therefore, development of a culture system which is capable of 
supporting preantral (and eventually primordial) follicles to a stage where the oocytes 
can be matured and fertilised in vitro may help to provide large amounts of 
homogeneous oocytes. Such a system may also allow identification of factors 
necessary for normal follicular development and acquisition of oocyte developmental 
competence. 
In the preliminary experiments described in chapter 3, the effects of FSH and 
IGF-1 on follicular growth using a serum-free culture system will be determined. In 
addition, follicular differentiation will be assessed by measurement of oestradiol 
secretion throughout the culture period. In chapters 4 and 5, regulation of ECM 
remodelling in vitro will be investigated. The specific aims of chapter 4 are (1) to 
determine whether MIMPs are secreted by bovine follicles in vivo; (2) to identify 
secretion of MIMPs and TIMPs by preantral follicles in vitro, and assess these factors 
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as markers of follicular development; and (3) to determine whether IGF-1 affects 
MItvlIP and TIMIP secretion in vitro. Chapter 5 will assess the effects of ascorbic acid, 
a factor involved in basement membrane remodelling, on bovine follicle development 
in vitro. Follicle growth and basement membrane integrity will be assessed during the 
culture period, and the effect of ascorbic acid on follicular morphology, MN'IIP 
production, oestradiol secretion and follicular cell death will be investigated. In 
chapter 6, we will further investigate the effects of IGF- I on preantral follicle 
development in vitro, using histological and immunocytochemical methods. In 




General Materials and Methods 
Chapter 2 
2.1. Follicle Isolation 
2.1.1. Dissection Medium 
Dissection medium was used for bench manipulation of ovarian material, and was 
prepared as follows. Leibovitz's medium (GIBCO BRL, Life Technologies Ltd, 
Paisley, Renfrewshire, UK) was supplemented with sodium pyruvate (2 MM), 
glutamine (2 mM), BSA (3 mg/ml), penicillin G (75 [ig/ml) and streptomycin (50 
tg/ml). Dissection medium was heated to 37 °C before use. All chemicals were from 
Sigma Chemicals, Poole, Dorset, UK unless otherwise stated. 
2.1.2. Collection of Cortical Slices 
Bovine ovaries from random stages of the oestrous cycle were obtained from an 
abattoir and transported at 25-30 °C in M199 (HEPES buffered) media supplemented 
with sodium pyruvate (2 mM), glutamine (2 mM), BSA (3 mg/ml), penicillin G (75 
tg/m1) and streptomycin (50 ig/m1). In a laminar flow hood, ovaries were rinsed 
with 70% ethanol, and fine slices of ovarian cortex were taken using a scalpel and 
placed in dissection medium. 
2.1.3. Micro-dissection 
In a petri dish under a dissecting microscope (Olympus, UK) fitted with a calibrated 
eyepiece graticule (Graticules Ltd, Tonbridge, Kent, UK), preantral follicles (100-
200 .tm) were isolated from the cortical slices using fine 25 G needles (Merck Ltd, 
Lutterworth, UK) attached to syringe barrels (Figure 2.1). Approximately 15 to 30 
follicles were isolated on each dissection day. Follicles with an intact basement 




2.2. Follicle Culture 
2.2.1. Culture Medium 
Basic culture medium was prepared as follows. McCoy's 5a medium with 
bicarbonate and HEPES (20 mM) was supplemented with BSA (0.1%), L-glutamine 
(3 mM), penicillin (100 lU/mi), streptomycin (0.1 mg/ml), transferrin (2.5 g/ml), 
selenium (4 ng/ml), androstenedione (10 7M) and insulin (10 ng/ml). Medium was 
filter sterilised (syringes: Merck; filters: Corning Costar, UK) and heated to 37 T. 
This basic medium was used at the beginning of this research project. Ascorbic acid, 
as described below, was added to culture medium in later experiments. 
2.2.1.1. Ascorbic Acid 
During the culture of murine preantral follicles, 50 p.g/mI ascorbic acid (L-ascorbic 
acid, sodium salt) was shown to improve follicle survival by reducing the incidence 
of basement membrane rupture, and by reducing apoptotic cell death (Murray et al., 
2001). Following this discovery, the effect of ascorbic acid was investigated in our 
culture system, as described in chapter 5. Subsequently, ascorbic acid was added to 
all culture medium. Aliquots of stock medium containing ascorbic acid were stored 
at —70 °C, and added fresh during culture medium changes. 
2.2.2. Culture 
Preantral follicles (100-200 m) were cultured individually in 96 well plates (Bibby 
Sterilin Ltd, Stone, Staffs, UK) in 250 jil of culture medium in the absence of serum 
(Figure 2.1). Plates were incubated for 6 days in a sterile humidified air atmosphere 
with 5% CO2 at 37 °C. Follicle diameters, taken on perpendicular planes, were 
measured under the dissection microscope on days 0, 2, 4 and 6. Half of the medium 
was replaced every second day, and this conditioned medium was stored at -20 °C 
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At the end of the culture period, follicles were fixed overnight in Bouin's solution 
(70% picric acid, 25% formaldehyde, 5% glacial acetic acid) or in 4% 
paraformaldehyde (4% paraformaldehyde in dH20, 0. 1M NaOH, 0. 1M Na phosphate 
pH 7, 4°C). The fixative was removed and replaced with 70% ethanol until required. 
Addition of a small amount of eosin (Merck) to the 70% ethanol aided visualisation 
of follicles during processing. 
2.3.2. Processing of Follicles for Morphological Assessment 
2.3.2.1. Processing of samples 
Follicles for morphological assessment were dehydrated by repeated changes through 
a series of increasing ethanol concentrations up to absolute ethanol. Absolute ethanol 
was replaced with cedar wood oil (Merck) for a minimum of 24 hours, then the oil 
was cleared from the follicles using toluene (in a fume hood) for 30 mm. Follicles 
were embedded in paraffin wax (Merck) at 60 °C, with changes every hour for 4 h to 
remove all traces of toluene. 
2.3.2.2. Sectioning and mounting 
The samples were sectioned at 6 pm using a microtome (Leica UK Ltd, Milton 
Keynes, UK). The sections were floated onto gelatin-coated slides (Merck) (prepared 
by dipping in a solution of 1% gelatine, 0.1% chromic potassium sulphate in dH 20) 




Sections were dewaxed in xylene for 15 minutes and taken down through a series of 
ethanol concentrations (absolute to 70%). The staining procedure was as follows (for 
reagent preparation see Drury and Wallington, 1976): Bouins fixative was removed 
from sections by dipping slides in 70% ethanol with lithium carbonate. Slides were 
rinsed in tap water and placed in Harris' Haemotoxylin (5 mm), rinsed in water again 
and placed in Scott's tap water substitute. Sections were rinsed in tap water and 
placed in Eosin (2 mm, 1:1 solution), dipped in tap water and placed in potassium 
alum (Merck) (3 mm), and rinsed again. The sections were dehydrated through a 
series of ethanol concentrations and placed in xylene. The sections were mounted 
using DPX mounting medium (Merck) and a glass coverslip. 
2.3.3. Processing of Follicles for Immunocytochemistry 
2.3.3.1. Processing of samples 
Follicles were processed and embedded as described in 2.3.2.1. 
2.3.3.2. Sectioning and mounting 
The samples were sectioned at 6 I.Lm using a microtome (Leica), mounted on charged 
slides (Merck), and allowed to dry overnight at 37 T. Slides were stored until 
required. 
2.3.3.3. Immunocytochemistry 
Samples were dewaxed in xylene and rehydrated from ethanol to distilled water, and 
washed in PBS (2x5 mm, Sigma). Antigen retrieval was performed by placing 
sections in 0.0IM citrate buffer (10 min microwave (800W), 20 min at RT, 0.19% 
citric acid (anhydrous) in dH 20, pH 6). Sections were washed in PBS (2x5 mm), 
placed in 3% hydrogen peroxide for 10 min and washed (2x5 mm, PBS). Sections 
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were placed in horse serum from a Vectastain ABC-Elite kit (Vector Laboratories, 
Southgate, UK) for 20 min at RT, followed by incubation at 37 °C with primary 
antibody (1 hr, 85 j.tg/ml Ki67-NMI [Novocastra Laboratories, Newcastle Upon 
Tyne, UK]). Negative controls were incubated with 1 mg/ml mouse IgG (Novocastra 
Labs) for 1 hr at 37 °C. Sections were washed (2x5 mm, 1% Tween 20 in PBS) and 
incubated with a biotinylated secondary antibody (Vector Labs, as kit) for 30 min at 
RT, and washed (2x5 mm, 1% Tween 20 in PBS). Slides were incubated with a 
tertiary antibody (Vector Labs, as kit) for 30 min at RT, and washed (2x5 mm, 1% 
Tween 20 in PBS). Localisation of the antigen was performed by incubation with 
DAB (Vector Labs, as kit) for 6 mm. Slides were washed in dH 20, counterstained 
with haematoxylin, dehydrated and mounted. 
2.3.4. Collection of Histological Results 
Histological measurements and observations were made under the light microscope 
with a crossed micrometer (Graticules Ltd). The section containing the oocyte 
nucleolus, or if this was absent, the largest cross-section of the oocyte was used for 
observations and measurements. Follicle and oocyte sizes were measured, and 
proliferation was assessed by counting the number of granulosa and theca cell layers. 
Granulosa cell death was measured by counting the number of pyknotic cells and 
expressing them as a percentage of the total number of granulosa cells: atretic 
follicles were defined as those with >5% pyknotic nuclei (Byskov, 1974). Theca cell 
health was assessed in two ways: (a) by the level of pyknosis, as defined above, and 
(b) by the number of layers present, with < 3 layers indicating theca degeneration. 
Oocytes were classed as healthy only if they were morphologically normal, and 
contained an intact germinal vesicle. Misshapen oocytes, or those that were absent or 
contained no germinal vesicle were classed as degenerate. 
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Growth and Differentiation of Bovine Preantral 
Follicles in a Serum-free Culture system 
Chapter 3 
3.1. INTRODUCTION 
Ovarian folliculogenesis is regulated by both endocrine and intraovarian mechanisms 
which co-ordinate the processes of somatic cell proliferation and differentiation. As 
discussed in chapter 1, FSH and IGFs are thought to be principal regulators of 
follicular development. 
Follicles can develop from the primordial to the late preantral stage in the 
complete absence of gonadotrophins (Dufour etal., 1979). However, the 
involvement of FSH in the development of small follicles is supported by the 
presence of binding sites/receptors for FSH in granulosa cells of cows (Wandji etal., 
1992) and other mammals (Monniaux and de Reviers, 1989; Eckery et al., 1997). 
Furthermore, FSH has been reported to stimulate growth (Qvist etal., 1990; 
Gutierrez etal., 2000); antrum formation (Roy and Greenwald., 1989; Hirao etal., 
1994; Gutierrez etal., 2000); oestradiol production (Qvist etal., 1990) and LH 
responsiveness (Boland etal., 1993) of preantral follicles in vitro. As the influence of 
FSH varies during follicular growth and development (Nayudu and Osborn, 1992; 
Qvist etal., 1990), account must be taken of this in a long term culture system. 
IGFs influence a variety of biosynthetic processes in ovarian granulosa and 
theca cells, as well as mitotic activity in ovarian granulosa cells (Giudice, 1992). 
This intraovarian IGF autocrine/paracrine system appears to regulate ovarian 
follicular development and steroidogenesis, either alone or in synergy with 
gonadotrophins (Giudice, 1992). The IGF system has been well characterised in 
antral follicles, but there are fewer studies on the effects of IGFs at earlier stages of 
follicular development. In mice, IGF-1 is associated with the growth and survival of 
rapidly expanding large preantral and early antral follicles (Adashi etal., 1997; 
Wandji et al., 1998). However, differences in temporal and spatial production of 
IGF-1 between rodents and domestic species suggests different mechanisms of action 
(Leeuwenberg etal., 1995; Yuan etal., 1996; Gutierrez et al., 1996; Wandji et al., 
1998; Schams etal., 1999). 
The aims of our initial experiments were to determine the action of FSH and 
IGF-1 on the growth of bovine preantral follicles in a serum-free culture system. This 
work was initiated after Ralph (1996) implicated a role for FSH in stimulation of 
40 
Chapter 3 
bovine preantral follicle development in vitro. Subsequently, Gutierrez et al. (2000) 
used a long-term serum-free culture system to determine that both FSH and IGF-1 
were beneficial to bovine preantral follicle and oocyte development. Ideally, it is 
preferable to use a serum-free system in order to assess the requirements for normal 
follicular development without the presence of unknown serum factors. 
In the current chapter, preliminary experiments to investigate the effects of 
FSH and IGF-1 on follicular growth using a serum-free culture system (Gutierrez et 
al., 2000) were performed. In addition, follicular differentiation was assessed by 
measurement of oestradiol secretion throughout the culture period. One modification 
made to the basic culture system was the inclusion of ascorbic acid in the culture 
medium in some of the experiments. In mouse preantral follicle culture, ascorbic acid 
was shown to improve follicle survival by reducing the incidence of basement 
membrane rupture, and by reducing apoptotic cell death (Murray etal., 2001). 
Following this discovery, the effect of ascorbic acid on bovine follicular 
development in vitro was investigated. This will be discussed in depth in chapter 5. 
For the purposes of the current chapter, it should be noted that initial experiments 
were performed in the absence of ascorbic acid. 
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3.2. MATERIALS AND METHODS 
3.2.1. Follicle Isolation and Culture 
Preantral follicles (100-200 tm) were isolated from bovine cortical slices and 
cultured individually under the same conditions for 6 days as described in chapter 2. 
3.2.2. Treatments 
3.2.2.1. Treatment with LR3 IGF-1 and FSH in the absence of ascorbic acid 
Basic culture medium (control) was prepared as described in 2.2.1. The analogue 
Long R3 IGF- 1 (LR3 IGF- 1), which does not bind to IGF binding proteins, was 
purchased from Gropep Pty Ltd, Adelaide, SA. The FSH (NIDDK-oFSH-20) was 
obtained from Dr Parlow, National Hormone and Pituitary program, Torrance, USA. 
The treatment groups were: 
(1) Control (n=61) 
(2) 10 ng/ml LR3 IGF- 1 (n=72) 
(1) Control (n=38) 
10 ng/ml LR3 IGF- 1 (n=3 2) 
1 ng/mI FSH (n=36) 
10 ng/ml LR3 IGF-1 + 1 ng/ml FSH (n=35) 
3.2.2.2. Treatment with FSH in the presence of ascorbic acid 
Basic culture medium containing ascorbic acid (control) was prepared as described in 
2.2.1.1. The treatment groups were: 
Control (n=14) 
10 ng/ml FSH (n=15) 
100 ng/ml FSH (n=32) 
42 
Chapter 3 
3.2.2.3. Treatment with LR3 IGF-1 and recombinant IGF-1 in the presence of 
ascorbic acid 
Basic culture medium containing ascorbic acid (control) was prepared as described in 
2.2.1.1. Human recombinant IGF-1 (hrIGF-1) was purchased from Sigma. The 
treatment groups were: 
Control (n=79) 
10 ng/mI LR3 IGF-1 (n=79) 
10 ng/ml hrIGF-1 (n80) 
3.2.3. Measurement of Oestradiol by Double Antibody Radioimmunoassay 
Concentrations of oestradiol in unextracted culture media from experiments 3.2.2.2 
and 3.2.2.3 were determined by radioimmunoassay as described previously (Webb et 
al., 1985). Briefly, each standard (100 tl oestradiol 170; 0-1000 pmolIl [NHS Labs]) 
was dispensed into assay tubes (Camlab, Cambridge, UK) in quadruplicate. Samples 
of culture medium (25 .tl) were made up to 100 .tl using PBS-Gel assay buffer (0.05 
M PBS [Sigma] with 0.1% gelatine [Merck] and 0.1% sodium azide [Sigma]), and 
dispensed in duplicate. A 100 pi aliquot of first antibody (1: 1,500 000 in PBS-Gel) 
was added to the samples, followed by 100 l.Ll of iodinated steroid (1125  oestradiol 
[NHS Labs]; approximately 10,000 counts per min).The assay was incubated 
overnight at 4 T. Equal volumes of normal sheep serum (1:200 in PBS-Gel [SAPU]) 
and second antibody (sheep anti goat; 1:20 in PBS-Gel [SAPU]) were mixed and 250 
i.ti added to the samples. Following an overnight incubation at 4 °C, 250 p.1 PBS-Gel 
containing 1% Tween 20 (Sigma) was added and the tubes were centrifuged (30 mm, 
3000 rpm, 4 °C). The supernatants were discarded, the tubes drained for 20 mm, and 
the radioactivity in the precipitates counted on a gamma counter (LKB Wallac, 1261 
Multigamma). Quantification of oestradiol was performed using AssayZap (Software 
Phil Taylor 2000, distributed by Biosoft). The sensitivity of the assay was 10 pg/ml. 
The intra-assay coefficient of variation was <10 %. 
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3.2.4. Statistical Analyses 
Mean follicle diameter and oestradiol production between experimental groups on 
every second culture day were compared using a one-way ANOVA, with subsequent 




3.3.1. Follicular Growth 
3.3.1.1. Effect of FSH onfollicular growth 
Follicles were cultured for 6 days in control medium (n=14) or in medium containing 
either 10 nglml FSH (n=15) or 100 ng/ml FSH (n=32). There was significant follicle 
growth over 6 days in all groups (p< 0.01) (Figure 3.1). FSH did not increase follicle 














Day of Culture 
Figure 3.1. Effect of FSH on follicular growth. Growth of preantral follicles in 
control medium (blue) or in the presence of FSH (red: 10 ng/ml; yellow: 100 ng/ml). 
Values are mean ± SEM. Growth is significant between Days 0 and 6 within 
treatment groups (p< 0.01). 
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3.3.1.2. Effect of LR3 IGF-1 on follicular growth 
Follicles were cultured for 6 days in the presence (n=72) or absence (n=6 1) of LR3 
IGF- 1, with follicle diameters being measured every second day. For analysis of 
growth in this initial experiment, follicles were separated into two size classes: 
preantral (<150 m; n60), and large preantral (150-200 tm; n=73). As Figure 3.2 
illustrates, significant follicular growth occurred over 6 days in the presence and 
absence of LR3 IGF-1 in both preantral and large preantral follicles (p< 0.01). No 
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Figure 3.2. Effect of LR3 IGF-1 on follicular growth. Growth of (a) preantral 
and (b) large preantral follicles in the presence (closed circles) and absence (open 
circles) of LR3 IGF-1. Values are mean ± SEM. Growth is significant between Days 





3.3.1.3. Effect of LR3 IGF-1 and FSH on follicular Growth 
Follicles were cultured for 6 days in control medium (n=38) or in the presence of 
LR3 IGF-1 (n=32), FSH (n=36) or LR3 IGF-1 + FSH (n=35). Significant follicular 
growth occurred over 6 days in all treatment groups (Figure 3.3) (p< 0.01). There 
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Figure 3.3. Effect of FSH and LR3 IGF-1 on follicular growth. Growth of 
preantral follicles in control medium (dark blue) or in the presence of LR3 IGF-1 (10 
ng/ml, red), FSH (1 ng/ml, light blue) or LR3 IGF-1 + FSH (yellow). Values are 




3.3.1.4. Effect of recombinant IGF-1 on follicular Growth 
Follicles were cultured for 6 days in control medium (n79) or in medium containing 
recombinant IGF-1 (n80) or LR3 IGF-1 (n=79). As illustrated in Figure 3.4, there 
was significant follicle growth over 6 days in the presence and absence of IGF-1 or 
LR3 IGF-1 (p< 0.01). At the end of culture, there was no significant difference in 
diameter between control follicles and follicles treated with IGF-1 or LR3 IGF-1. 
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Figure 3.4. Effect of recombinant IGF-1 on follicular growth. Growth of 
preantral follicles in control medium (blue) or in the presence of recombinant IGF-1 
(yellow) or LR3 IGF-1 (red). Values are mean ± SEM. Growth is significant between 
Days 0 and 6 within treatment groups (p< 0.01). 
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3.3.2. Oestradiol Secretion 
3.3.21 Effect of JGF-1 and FSH on oestradiol secretion 
Medium from follicles cultured in control medium (Day 2, w=43; Day 4, n=37; Day 
6, n=41), or in the presence of LR3 IGF-1 (Day 2, n=26; Day 4, n=23; Day 6, n=26), 
recombinant IGF-1 (Day 2, n=23; Day 4, n=23; Day 6, n=28) or FSH (10 nglml: Day 
2, n=14; Day 4, n= 15; Day 6, n=14; 100 ng/ml: Day 2, n=30; Day 4, n=31; Day 6, 
n=24) was analysed for oestradiol content by radioimmunoassay. During the 6 day 
culture period, there was significant (p< 0.01) oestradiol secretion by follicles in the 
presence and absence of LR3 IGF-1, recombinant IGF-1 and FSH (Figures 3.5 and 
3.6). There was no significant difference in oestradiol secretion between IGF-1 
groups and controls. On Day 2 and 4 of culture, 10 ng/ml and 100 ng/ml FSH 
stimulated oestradiol secretion (p< 0.05) (Figure 3.6). However, only 100 nglml FSH 
maintained this increase by Day 6 (p< 0.01). 
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Figure 3.5. Effect of IGF-1 on oestradiol secretion. Oestradiol secretion by 
preantral follicles cultured in control medium (blue) or in the presence of LR3 IGF-1 
(red) or recombinant IF-i (yellow). Values are mean ± SEM. Oestradiol secretion 
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Figure 3.6. Effect of FSH on oestradiol secretion. Oestradiol secretion by 
preantral follicles cultured in control medium (yellow) or in the presence of 10 ng/mI 
FSH (blue) or 100 ng/mI FSH (red). Values are mean ± SEM. Oestradiol secretion is 





During the early stages of follicle development in vitro, it is important to provide 
factors in the culture medium which stimulate follicle proliferation and oocyte 
growth, without inducing precocious differentiation. Development of bovine 
preantral follicles to a stage where the oocyte can be matured in vitro will require a 
long term culture period, and the demands of the follicle will change according to the 
stage of development reached. 
The role of FSH in the development of rodent preantral follicles has been 
demonstrated by the finding that such follicles can be efficiently grown in vitro only 
under gonadotrophin stimulation (Nayudu and Osborn, 1992; Eppig and Schroeder, 
1989; Cortvrindt etal., 1997). However, it is likely that there is a difference between 
rodent and bovine species regarding the absolute requirement for FSH for the growth 
of preantral follicles in vitro. The state of differentiation of the granulosa cells may 
account for this, given that fundamental differences exist between follicles from 
these species both in terms of follicle size and rate of development. In vivo, murine 
follicles develop from the primordial to the preovulatory stage in approximately 21 
days (Pederson, 1970), whereas in cattle and sheep, it is estimated that 4 to 6 months 
is required for a primordial follicle to reach the Graafian stage (Gosden et al., 1994; 
Lussier etal., 1994). 
Though not a mandatory factor, FSH has been shown to stimulate the growth 
of bovine and ovine preantral follicles (Huishofet al., 1995; Wandji et al., 1996; 
Cecconi etal., 1999; Gutierrez et al., 2000). Ralph (1996) showed that FSH 
increased follicle diameter in large preantral/early antral (150-210 pim) follicles, but 
had no effect on small preantral (90-150 p.m) follicles. The concentration of FSH 
used in culture, as well as follicle starting size may account for variation in the effect 
of FSH within different culture systems. We have shown that physiological 
concentrations of FSH do not increase follicle diameter over control levels 
throughout a 6 day culture period. In the study by Ralph (1996), the follicles which 
were stimulated by FSH were entering the antral phase of development, which is 
characterised by increased dependence on gonadotrophin support. Cecconi and 
colleagues (1999) showed that FSH concentrations of 0.01-1 .tg/ml stimulated 
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growth of ovine follicles during a six day culture. However, this system contained 
serum, as did the system employed by Ralph (1996). Using the serum-free system we 
have described, Gutierrez et al. (2000) showed that a low concentration (1 ng/mI) of 
FSH stimulated bovine preantral follicle growth during a 28 day culture period. This 
extended incubation may have allowed sufficient granulosa cell differentiation to 
occur, thus allowing FSH to have a stimulatory effect. 
Granulosa cell proliferation in small bovine follicles has been found to be 
increased by FSH (Wandji etal., 1996). In contrast, Ralph (1996) reported that an 
accumulation of intercellular fluid in FSH-treated follicles may have been 
responsible for increased follicle diameter, rather than an increase in granulosa cell 
number. This finding questions the usefulness of follicle growth as a representation 
of physiological development. We have shown here that although FSH does not 
increase follicle diameter during culture, it significantly increases oestradiol 
secretion by preantral follicles from Day 2 of culture onwards. This dissociation of 
follicle growth and oestradiol synthesis confirms previous findings in sheep, human 
and mouse follicles (Cecconi etal., 1999; Schoot et al., 1992; Boland and Gosden, 
1994). 
Since no IGF expression has been detected in bovine follicles until after 
antrum formation, it might be hypothesised that IGFs may play a limited role in 
preantral follicle development. However, IGF-1 binding has been demonstrated in 
bovine preantral follicles (Wandji et al., 1992) and type 1 IGF receptor mRNA has 
been detected in bovine oocytes, granulosa and theca cells from the preantral stage 
(Armstrong et al., 2000). Therefore, the source of IGF ligand for preantral follicles in 
vivo is probably endocrine rather than paracrine or autocrine. As antral follicle 
development proceeds, intrafollicular as well as endocrine mechanisms are likely to 
be involved in IGF regulation of follicular processes (Armstrong et al., 2000). For 
example, IGF-Il mRNA has been detected at low levels in granulosa cells of bovine 
antral follicles, with an increase after selection (Schams et al., 1999), and also in 
theca cells (Gutierrez etal., 1996), indicating that endogenous IGF-1 may be 
important in the later stages of folliculogenesis, for example in relation to LH 
responsiveness. This growth factor has also been reported to augment granulosa cell 
FSH receptor expression in mouse follicles (Zhou etal., 1997). IGF-1 did not 
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increase follicle growth or oestradiol secretion by preantral follicles in this study. 
Furthermore, follicle growth was not stimulated by a combination of IGF-1 and FSH. 
Previously, IGF- 1 has been reported to have a stimulatory effect on bovine preantral 
follicle and oocyte growth in long term culture (Gutierrez et al., 2000). However, 
that study employed a longer culture period than is reported here. As discussed 
earlier, as well as allowing a response to FSH, the extended incubation period may 
have allowed the granulosa cells to differentiate sufficiently to respond to IGF- 1 
stimulation. Therefore, it is necessary to investigate the stage-specific requirements 
of the oocyte and follicular cells for IGFs. 
In summary, we found no effect of IGF-1 or FSH on follicle growth during a 
six day culture period. However, increased oestradiol secretion by FSH-treated 
follicles implies that follicle growth and granulosa cell steroidogenic activity may be 
differentially regulated. The observed elevation of oestradiol may be due to 
precocious granulosa cell differentiation, which may be detrimental to the follicle in 
the early stages of development. 
The results presented here demonstrate that preantral follicles can be grown 
in a serum-free culture system. The following chapters will use this system to further 
investigate follicle and oocyte development during the early stages of 
folliculogenesis. Moreover, rather than relying on follicle growth as a indicator of 
follicle development, we will examine follicle and oocyte morphology in vitro. 
Furthermore, as follicular requirements will change throughout development in a 




Matrix Metal loproteinases and their Endogenous 
Inhibitors: Markers for Follicle Health 
Chapter 4 
4.1. INTRODUCTION 
Compared to the current knowledge of regulation of follicular development by 
hormones and growth factors, relatively little is known of the cellular biology of 
developing follicles. The follicular basement membrane is a specialised extracellular 
matrix which influences epithelial cell migration, proliferation and differentiation, and 
can selectively retard the passage of molecules from one side of the basement 
membrane to the other (Rodgers et al., 2000). Previously, culture systems for bovine 
preantral follicles have resulted in the loss of theca cells (Ralph, 1996; Gutierrez etal., 
2000) or rupture of the basement membrane (Gutierrez et al., 2000) in some follicles. 
During follicular growth, turnover and reconstruction of the basement 
membrane is facilitated by matrix metalloproteinases (M1MPs). These are zinc and 
calcium-dependent enzymes that are capable of degrading the protein components of 
the extracellular matrix (ECM) (Smith etal., 1997). tvllvlPs are regulated by tissue 
inhibitors of metalloproteinases (TIMPs), and are responsible for the reconstruction of 
the basement membrane at the time of ovulation, and during corpus luteum formation 
(Zhao and Luck, 1996). The MMPs involved in the breakdown of collagen IV (a 
major constituent of the basement membrane) are the gelatinases MIMP-2 and MIMP-
9. The main follicular sources of MIMPs and TIlviPs are thought to be the granulosa 
and theca cells (Zhao and Luck, 1996; Smith et al., 1994), but TIMP protein has also 
been detected in the oocyte (Bagavandoss, 1998). 
The role of growth factors in control of follicular cell proliferation has been 
studied extensively. As discussed in Chapter 1, growth factors are often secreted 
constitutively and sequestered in the ECM in an inactive form or in association with 
specific binding proteins. Liberation of these factors by proteolysis of the ECM is a 
key process in regulation of availability of growth factors and their activities within 
developing follicles. MMPs have been reported to function as IGFBP-degrading 
proteinases, both in vitro and in vivo (Fowlkes et al., 1994a; Fowikes et al., 1994b; 
Thrailkill etal., 1995). Therefore, MirviPs, beyond their previously described roles as 
extracellular matrix degrading enzymes, may also exert effects on cellular growth and 
differentiation via degradation of growth factor binding proteins. 
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Adequate basement membrane turnover is essential for follicular growth and 
survival. However, previous culture systems for bovine preantral follicles have 
resulted in the loss of theca cells (Gutierrez el al., 2000; Ralph, 1996) or rupture of 
the basement membrane (Gutierrez et al., 2000) in some follicles. Therefore, factors 
involved in basement membrane remodelling may be useful indicators of follicular 
health. The aims of this chapter were (1) to determine whether MMPs are secreted by 
bovine follicles in vivo; (2) to identify secretion of MIMPs and TIMPs by preantral 
follicles in vitro, and using growth and morphological data, assess these factors as 
markers of follicular development; and (3) to determine whether IGF-1 affects MMP 
and TIMP secretion in vitro. 
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4.2. MATERIALS AND METHODS 
4.2.1. Collection of Follicular Fluid 
Bovine ovaries were collected as described in 2.1.2. Follicular fluid was aspirated 
from antral follicles (0.65 mm-2.5 cm; n=6) present on the surface of the ovaries using 
syringes fitted with 25 G needles. Follicular fluid aliquots were stored at -20 °C for 
subsequent MMP analysis. 
4.2.2. Follicle Isolation and Culture 
Preantral follicles (<200 pm) were isolated from bovine cortical slices and cultured 
individually for 6 days as described in chapter 2. Half of the culture medium was 
replaced every second day, and this conditioned medium was stored at -20 °C for 
subsequent M1MP/TIM1P analysis. 
4.2.3. Treatments 
Culture medium was prepared as described in 2.2.1. For the treatment group, 10 
ng/ml of LR3 IGF-1 (Gropep) was added to the control medium. 
4.2.4. Detection of Secretion of MMPs and TIMPs 
4.2.4.1. Detection of secretion of MMP-2 and J%'IMP-9 by gelatin zymography 
Cuture medium was collected every second day, and MIvIP/TIIVIIP analysis done at 
random time points. MIMP-2 and NEAP-9 activities were detected in follicular fluid 
(n=6) and culture medium (n=52) by gelatin zymography as described previously 
(Riley et al., 1999). In brief, 100 p1 samples of culture medium or follicular fluid were 
dialysed against distilled H 20 in small tube-o-dialysers (Chemicon International, 
London, UK) before being lyophilised and reconstituted in 7.5 p1 0.1% SDS in H 20. 
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Samples were separated by SDS-PAGE using 7.5% gels containing 1mg/mi gelatin on 
a minigel apparatus (Bio-Rad, Hemel Hempstead, UK). Gels were washed (2 x 15 
mm, 2.5% (v/v) Triton X-100; 2x2 mmn TBS xlO) then incubated overnight at 37 °C 
in digestion buffer (50 mM Tris; 0.2 M NaCl; 5 mM CaC1 2, 1 l.LM ZnC12; 0.02% 
(v/v)Brij-35) Gels were stained for 3 h at 23'C (0.5% Coomassie Blue R250 in 30% 
methanol / 10% glacial acetic acid in H 20), then destained (staining solution with 
Coomassie Blue omitted). This reveals clear bands where gelatin has been degraded 
by gelatinase activity. MIvIP-2 and IvllvIIP-9 were identified by comparison with 
molecular weight markers and control standards of human amniotic fluid collected 
during labour at term (Riley et al., 1999). 
4.2.4.2. Detection of secretion of TIMP-1 and TIMP-2 by reverse zymography 
TIMP activity was detected in culture medium (n=24) using a commercial kit 
(University Technologies), as described previously (Riley etal., 1999). Samples were 
lyophilised and reconstituted as before and separated by molecular weight by PAGE, 
using 12% gels containing gelatin (1 mg/ml) and a preparation of TvIMP-2 
(conditioned medium from BHK-21 cells that constitutively express MIMP-2; 
University Technologies Inc, Calgary, Canada). The gels were washed (50 mlvi Tris, 5 
mM CaCl2, 2.5% (v/v) Triton X-100) for 2.5 h at 23 °C, then incubated in digestion 
buffer (50 mlvi Tris, 5 mM CaCl 2) overnight at 37 T. After staining and destaining 
(as in zymography), TIMPs were represented by discrete dark bands on the gel, where 
inhibition of MAP-induced degradation of the gelatin substrate has occurred. TilviPs 
were identified by comparison with molecular weight markers and control standards 
of conditioned medium containing mouse TTMP-1, -2 and -3 expressed by transfected 
BHK cells (University Technologies). 
4.2.5. Histological Assessment 
At the end of the culture period, follicles were fixed and processed for histology as 
described in chapter 2. Granulosa cell death was measured by counting the number of 
pyknotic cells and expressing them as a percentage of the total number of granulosa 
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cells: atretic follicles were defined as those with >5% pyknotic nuclei (Byskov, 1974). 
Theca cell health was assessed in two ways: (a) by the level of pyknosis, as defined 
above, and (b) by the number of layers present, with < 3 layers indicating theca 
degeneration. 
4.2.6. Statistical Analyses 
With probability estimates for the occurrence of MlvIIPs and TIMPs having been 
calculated, Baye's Theorem (Clarke and Cooke, 1992) was applied in order to 
estimate the probability of granulosa or theca cell health, given the presence of MIMPs 
and TMs. Comparison of MMP and TRAP secretion between IGF-1-treated and 




4.3.1. Histological Assessment 
Histological observations were made using freshly isolated follicles (n=10), IGF-1 
treated follicles (n=24) and control follicles (n22). These results will be discussed in 
detail in chapter 6. For the purposes of the present study, follicular granulosa and 
theca cells were termed either healthy or degenerate according to the criteria set out 
in 4.2.5. Examples of follicles with healthy and degenerating somatic cells are shown 






Figure 4.1. Histological sections representing healthy and degenerating 
follicles. (a) a follicle with a healthy oocyte (o), even granulosa cells (g) with 
spacing that may be indicative of an early antrum (ea), and a differentiated theca 






4.3.2. Secretion of MMP-2, MMP-9, TIMP-1 and TIMP-2 Activities 
4.3.2.1. MMP secretion in vivo 
In this preliminary experiment, follicular fluid from 6 follicles (0.65 mm-2.5 cm 
diameter) was analysed for gelatinase activity. There was abundant MMP-2 activity 
and small amounts of MMP-9 activity in 5 out of 6 samples. A representative 
zymogram is shown in Figure 4.2. 









Figure 4.2. Representative gelatin zymogram showing gelatinase (MMP) 
activity secreted in 4 samples of follicular fluid from (A) a 0.65 mm follicle, (B) a 3 
mm follicle, (C) a 9 mm follicle and (D) a 2.5 cm follicle. 
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4.3.2.2. Effect of growth status on MMP secretion in vitro 
In the first in vitro experiment, culture medium from 20 follicles was analysed for 
gelatinase activity. Of these samples, 12 were from follicles observed to be growing, 
and 8 were from follicles which remained static prior to collection of medium. MMP-
2 activity was detected in all samples. However, only 50% of the static follicles and 
66.7% of the growing follicles, respectively, secreted MMP-9 into the culture 
medium. The preliminary gel indicated that there may have been an increase in MMP 
activity in growing follicles, as illustrated in Figure 4.3. However, after analysis of all 
samples, no significant correlation between MMP-2 or MMP-9 secretion and growth 
status was found. 
SG G G S S 	mw AF kDa 
MMP-9 (I) .-* 
MMP-2 (a) —* 





Figure 4.3. Representative gelatin zymogram showing gelatinase (MMP) 
activity secreted in samples of culture medium from static (S) and growing (G) 
bovine follicles. Human amniotic fluid was used as a positive control (AF). 
Molecular weight markers (mw) are as indicated (kDa). 
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4.3.2.3. Effect offollicle morphology on MMP and TIMP secretion in vitro 
Culture medium from 32 follicles was analysed for gelatinase activity, and 24 samples 
were analysed for the presence of TIrviPs. Examples of a zymogram demonstrating 
MIVIP-2 and MIVIP-9 activity, and a reverse zymogram showing TRAP-1 and TEMP-2 
secretion by follicles into the culture medium are shown in Figure 4.4. MMP-2 (72 
kDa) was found to be released by 87.5% of follicles, whereas MtvlP-9 (92 kDa) was 
secreted by 62.5% of follicles. Comparisons between zymographic analysis and 
morphology (Table 4.1) showed that if IvIIMP-9 was secreted during culture, the 
probability of these follicles having healthy (as determined by level of pyknosis) 
granulosa cells at the end of the culture period was 0.85. The probability of theca cell 
health (defined by the number of layers) was found to be 0.60. When TIMP-1 (28 
kDa) was released in vitro, (58% follicles), there was a probability of 0.79 that the 
follicles would have healthy granulosa or theca cells. When TRAP-2 (21 kDa) was 
produced (75% follicles), the probability of the follicles having healthy granulosa or 
theca cells was 0.78 and 0.67, respectively. There was no significant difference in 
M14P or TRAP secretion between IGF-l-treated and control follicles (Tables 4.2a and 
4.2b). 
Table 4.1. Effect of follicle morphology on MMP and TIMP secretion 
Secreted Factor Present 	Probability of 	Probability of Theca 
Granulosa Cell Health Cell Health 
MAP-9 0.85 0.60 
TIMP-1 0.79 0.79 
TIMIP-2 0.78 0.67 
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Table 4.2a. Effect of IGF-1 on MMP secretion 
MN'IP-2 Secretion 	MIMP-9 Secretion 
(% Follicles) (% Follicles) 
IGF-1(n17) 	 94.1 	 52.9 
Control (n13) 76.9 61.5 
Table 4.2b. Effect of IGF-1 on TIMP secretion 
TIMP- 1 Secretion 	TIMP-2 Secretion 
(% Follicles) (% Follicles) 
IGF-1 (n=8) 	 50 	 62.5 





















Figure 4.4. Representative gelatin zymogram (A) and reverse zymogram 
(B) showing gelatinase (MMP) and TIMP activities secreted in samples of culture 
medium. MMP-2 and MMP -9 or TIMP-1 and TIMP-2 presence is indicated in four 
follicles with granulosa cells (GC) that are healthy (H) or degenerate (D) and theca 




Regarding the preantral and early antral stages of follicular development, very little is 
known concerning the contribution of the various IvilviPs and associated regulators to 
follicular development. We have demonstrated that MMP-2 and MMP-9 are secreted 
into follicular fluid, and when MIMP-9 and TIMPs are secreted by preantral follicles in 
vitro, a follicle has a higher probability of being healthy (as determined by level of 
pyknosis in granulosa cells and number of theca layers) at the end of the culture 
period. However, the secretion of M1MPs was not correlated to follicle growth rate. 
There was also no significant difference in MMP and TIMP secretion by IGF- 1-
treated and control follicles. In the previous chapter, it was demonstrated that IGF- 1 
had no effect on follicular growth (as measured by follicle diameter) in our culture 
system. As will be discussed in chapter 6, we have also found no evidence of a 
difference between IGF-1-treated and control follicles in terms of somatic cell health. 
Several studies have investigated the distribution of MIVIPs and TilviPs at 
different stages of follicular development. In the ovary of neonatal rats, activity of 
MMP-2, but not MMP-9, has been detected, with visualisation of TIIMP- 1 in the 
oocyte (Bagavandoss, 1998). In PMSG-primed ovaries of rats, and also mice, MW-2 
is detected in the granulosa and theca cells, MrvlP-9 is restricted to thecal and 
interstitial cells, and TIIvIP-1 is located in blood vessels and theca cells (Hagglund el 
al., 1999; Bagavandoss, 1998; Reich etal., 1991). In addition, IvllvIP-9 is restricted to 
the theca cell layers in goat follicles of less than 3 mm (Garcia et al., 1997), and has 
been detected in differentiating granulosa cells in culture (Zhao and Luck, 1996) and 
subsequently in the developing corpus luteum in rats (Bagavandoss, 1998). 
Collectively, the results of these studies implicate the granulosa and theca cells as 
sources of MIJVIPs and TllvlIPs during follicular development. 
In vitro, secretion of MIMP-2 and MTvIP-9 from bovine thecal cells has been 
observed to increase in response to LH (Smith et al., 1997). This observation may 
imply that theca cells have a role in remodelling the basement membrane, or that the 
remodelling of vascular tissue present within the culture may be under gonadotrophin 
control. The regulation of MIvIIP activity is complex and may be controlled at the level 
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of transcription by growth factors, cytokines and hormones, with subsequent 
activation of secreted proforms, and inhibition by TIMPs (Hagglund etal., 1999). 
The mechanisms controlling remodelling at the gonadotrophin-independent stages of 
follicle development are unknown; thus, further investigations are required. IvDvlPs 
and TIMP5 also may be regulated depending on their specific spatial and temporal 
functions. The distribution of MIMP-9 in the steroidogenic cells of the theca layer, 
interstitium, and corpus luteum as well as its absence in the neonatal ovary 
(Bagavandoss, 1998) and the timing of expression (Chaffin and Stouffer, 1999), 
suggest a role in the remodelling and vascularisation associated with corpus luteum 
formation. The detection of M1MP-2 and MIVIP-9 during our study in cattle suggests a 
role for these enzymes at a much earlier stage than, to our knowledge, has been 
studied previously, and that MrvlP-9 and TIMIPs can now be used as non-invasive 
markers for assessing follicular quality in vitro. 
T]IMPs have been implicated in other processes involving cell growth. For 
example, TRAP- 1 has been associated with erythroid potentiating activity (Docherty 
et al., 1985) and T1MPs -1 and -2 have growth factor-like activities in some cell types 
(Hayakawa et al., 1994). The increased probability of follicular health when TilviPs 
were present in our study agrees with this function. Results of other reports suggest 
that TIMIP-1 is a facilitator of steroidogenesis (Duncan etal., 1996; Nothnick and 
Curry, 1996; Boujrad et al., 1995). Differences in TIMIP activity between atretic and 
non-atretic follicles during the late preantral and early antral stage may be a marker 
for the shift in steroidogenic capability and future selection of healthy follicles at this 
stage of development. The significance of the location of TIMP- 1 in the oocyte 
(Bagavandoss, 1998) is unclear, and during the early stages of folliculogenesis, a 
potential function for TIMPs as oocyte growth factors remains uninvestigated. Future 
experiments should assess if the correlation between MIVIIP and TIMP secretion with 
follicle quality in vitro also applies to oocyte health and development. This will allow 
us to better understand interactions between the oocyte and somatic cells regarding 
the coordination of oogenesis and folliculogenesis. 
In our study, follicles that did not maintain a differentiated thecal layer in vitro 
tended to be less healthy overall than follicles with thick, non-pyknotic theca cell 
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layers. Maintaining interplay between the oocyte and the surrounding somatic cells is 
vital to achieve normal folliculogenesis. Growth differentiation factor-9 (GDF-9), 
which is an oocyte-derived factor from the transforming growth factor-n superfamily, 
is required for sustaining follicular growth and differentiation after the primary (i.e. 
one-layer) follicular stage (Dong etal., 1996). Studies using knockout mice (Elvin el 
al., 1999; Dong et al., 1996) have shown that in the absence of GDF-9, follicles are 
incompetent to emit a signal that recruits theca cell precursors to surround the 
basement membrane (Elvin et al., 1999). Our observations confirm the importance of 
maintaining healthy theca cells and their connections with the granulosa layers in 
bovine follicle culture, and also support a role for these cell types in basement 
membrane remodelling during the early stages of folliculogenesis. Having said this, 
murine oocytes can obtain developmental competence and be fertilised in vitro in the 
absence of theca cells (Eppig and Schroeder, 1989; Eppig and O'Brien, 1996). 
However, there may be species differences regarding the requirement of the oocyte 
for theca cell factors in vitro. Conversely, the presence of theca cells may further 
enhance oocyte developmental competence in rodent systems. 
Further evidence for the role of theca cells in influencing follicular 
development is provided by recent studies in sheep (Wilson el al., 2001; Souza et al., 
2001). Bone morphogenetic proteins (BMPs), members of the TGF-3 superfamily, 
have been shown to be expressed in theca cells, and BMP receptors have been found 
in granulosa cells and oocytes of normal cycling rats (Shimasaki etal., 1999). 
Interestingly, the prolific Booroola phenotype is associated with a mutation in the 
BMP receptor type lB (BMPR1B) gene (Wilson et al., 2001; Souza etal., 2001). 
Hence a mutation in the BMP signalling system, which involves interaction between 
the oocyte and follicular cells, may contribute to the precocious follicle differentiation 
and increased ovulation rate observed in Booroola animals. 
In conclusion, we have detected MIMIP and TIMIP activity in vitro and 
identified MMP-9, TIMP-1, and TIMIP-2 as markers of follicular health. Elucidation 
regarding the action of MIMPs and THAN and the role of growth factors during 
follicle growth and antrum formation in an extended culture will provide insight into 
the complex processes involved in follicle and oocyte growth and development. 
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Improving our knowledge of the interactions between follicular cells and the 
extracellular matrix is necessary for maintaining the integrity of preantral follicles in 
vitro, thus sustaining follicular viability. 
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The Effect of Ascorbic Acid on Preantral Follicle 
Development In Vitro 
Chapter 5 
5.1. INTRODUCTION 
In the previous chapter, MIvIP-9 and TEMPS, which are involved in basement 
membrane remodelling, were identified as indicators of follicular health using a serum-
free culture system. This led to further investigation into factors that affect basement 
membrane turnover. One such factor is ascorbic acid (review: Luck el al., 1995). In 
the present chapter, the culture period is extended from 6 to 12 days, and the effect of 
ascorbic acid on the development of preantral follicles in vitro is investigated. 
Ascorbic acid, a dietary requirement for primates and a few other mammals, 
has been implicated in several processes associated with follicular and luteal 
development. It is widely distributed in animal tissues, with the highest concentrations 
being found in the pituitary, adrenal gland and gonads (Luck et al., 1995). Ascorbic 
acid accumulates in granulosa cells, theca interna, luteal cells, and in oocytes (Kramer 
et al., 1933; Hoch-Ligeti and Bourne 1948; Deane, 1952). Acting as an antioxidant, 
ascorbic acid has been implicated in the processes of hormone secretion, gonadal 
tissue remodelling and apoptosis (Luck et al., 1995). Adequate turnover of 
components of the follicular ECM is essential for normal follicle growth, follicle repair 
after ovulation (Himeno et al., 1984), and subsequent corpus luteum development 
(Luck and Zhao, 1993). In species with large follicles such as humans and cattle, there 
is a high demand for collagen IV (a major constituent of the basement membrane). 
Ascorbic acid has been implicated in the biosynthesis of collagen, both at the gene 
level (Padh, 1991) and during processing of the protein (Pinnell, 1985; Hulmes, 
1992). As discussed in the previous chapter, the enzymes involved in the turnover of 
collagen during follicle growth are the MN'IPs which are regulated by TIMPs. 
Ascorbic acid may act to regulate these factors (Pfeffer el al., 1998; Murray et al., 
2001). 
The presence of high concentrations of ascorbic acid in endocrine tissues is 
thought to be important for the production of steroid hormones (Tsuji et al., 1989). In 
cows, ascorbic acid levels in follicular fluid tend to be higher during the early part of 
the cycle (days 1-10 after ovulation) (Wise, 1987). This sequestration of ascorbic acid 
may be to allow rapid expansion of the follicle or to facilitate post-ovulatory 
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steroidogenesis (Luck et al., 1995). In contrast, it has been suggested that ascorbic 
acid at high concentrations inhibits steroidogenesis (Sanyal and Datta, 1979). Any 
effect of ascorbic acid on hormone synthesis during early follicle development remains 
to be clarified. 
The role of ascorbic acid as a free radical scavenger is well understood. It is 
thought that follicular atresia is initiated as a consequence of inadequate protection of 
maturing granulosa cells from the damaging effects of reactive oxygen species (Tilly 
and Tilly, 1995). Oxidants induce apoptosis in cultured granulosa cells, and addition 
ofFSH or antioxidants such as ascorbic acid inhibits this response (Tilly and Tilly, 
1995). In addition, addition of serum during culture reduces follicular apoptosis 
(McGee etal., 1997). As well as follicular atresia, ascorbic acid deficiency causes 
premature resumption of meiosis and oocyte destruction (Kramer el al., 1933). 
The present study aims to determine the effects of ascorbic acid on bovine 
preantral and early antral follicle development in vitro. Follicle growth and basement 
membrane integrity are assessed during the culture period, and the effect of ascorbic 
acid on follicular morphology, MrvlP production, oestradiol secretioñ and follicular 
cell death are investigated. In addition, the effect of serum on follicle growth and 
health is assessed. 
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5.2. MATERIALS AND METHODS 
5.2.1. Follicle Isolation and Culture 
Preantral follicles were isolated as described in chapter 2, and cultured for 6, 10 or 12 
days as described below. 
5.2.2. Treatments 
For the control group, preantral follicles were cultured individually for 12 days in 
medium described in 2.2.1. It should be noted that McCoys 5a medium already 
contains 0.5 tg/ml ascorbic acid in its standard composition. However, a 
concentration of 50 tg/ml has been reported to be effective in increasing follicle 
survival in mouse follicle culture (Murray el al., 2001). For the first treatment group, 
50 .ig/ml of L-ascorbic acid, sodium salt (Sigma) was added to the control medium 
and follicles were cultured for 12 days. The effect of foetal bovine serum (FBS 
[Sigma], 10%) on follicles from Day 6 of culture onwards was also investigated, with 
addition ofFBS to follicles in either ascorbic acid-treated or control groups. In 
addition, FBS was added to control or ascorbic acid-treated medium on Day 0 and 
follicles were cultured for 10 days. These treatment groups are illustrated in Figure 
5.1. In addition, follicles were cultured for 6 days in control medium (n=22) or 
ascorbic acid medium (n=10) in the absence of serum, and these follicles were fixed 
for histological analysis. Follicle diameters were measured under the dissection 
microscope every second day, and follicles which maintained their 3D morphology 
were defined as intact. Half of the medium was replaced every second day, and this 
conditioned medium was stored at -20 °C for subsequent MMP analysis, or for 
analysis of oestradiol content. 
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Day 0 	 Day 6 	Day 10 Day 12 
F- I I 
Control (n=8 1) 	 Control media 
Treatment 1 (n=82) 	
+ Ascorbic acid 
Treatment 2 (n33) 	
+ Ascorbic acid 	± Ascorbic acid 
+ FBS 
Treatment 3 (n=33) 	
Control media 	+FBS 
Treatment 4 (n=20) 	
+FBS 
Treatment 5 (n20) 	
+ Ascorbic acid 
+FBS 
Figure 5.1. Ascorbic acid and serum treatment groups 
5.2.3. Histological Assessment 
Control follicles (n22) and follicles treated with ascorbic acid (n=10) were fixed on 
Day 6 and processed for histological analysis as described in chapter 2. In addition, a 
proportion of follicles treated with ascorbic acid (n1 1) were fixed on Day 12 and 
processed for histology. 
5.2.4. Detection of Apoptotic Cell Death in Follicle Wholemounts by TUNEL 
At the end of the 12 Day culture period, follicles were transferred to 24 well culture 
plates (Corning Costar) and washed (10 mm, PBS, 37°C). Cultured follicles (n35) 
and freshly isolated follicles (n=8) were permeabilised and prefixed (40 mm, 0.5% 
Triton X-100, 0.25% paraformaldehyde (PF) in PBS at 37 °C) then fixed (30 mm, 4% 
PF in PBS, RT) washed in PBS (2x10 mm) and stored (0.02% NaN3 in PBS, 4 °C). 
Follicles were washed and equilibrated to RT with PBS (20 mm; 2x10 mm). Samples 
were then incubated with proteinase K (Roche Diagnostics, Lewes, UK) (40 mm, 
17.1 tg/m1 in PBS, 37 °C), refixed at RT (20 mm, 3% PF in PBS) and washed (10 
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mm, 0.01% Triton X-100 in PBS; 2x10 min PBS). A preincubation with TdT buffer 
(10 mm, 30 mM Tris-HCI pH 7.2, 140 mM sodium cacodylate, I mlvi cobalt chloride) 
was carried out before incubation with TUNEL reaction mixture (2.5 h, 37°C in dark) 
from an In Situ Cell Death Detection Kit, Fluorescein (Roche) which was prepared 
according to the manufacturer's instructions. 
Follicles were washed in PBS (2x10 mm, in dark), and incubated with 
propidium iodide (1 h, 2.5 .tg/ml, RT) in bovine pancreatic RNase A (Roche). 
Samples were washed (20 mm, 0.01% Triton X-100 in PBS; 2x10 min PBS) and 
equilibrated in 50% Vectashield (Vector Laboratories Ltd, Southgate, UK) overnight 
at 4 °C. Follicles were mounted in 100% Vectashield on concave microscope slides 
(TAAB Laboratories Ltd, Aldermaston, UK) and stored at 4 °C in the dark. 
Follicles were analysed for fluorescein dUTP incorporation using the Leica 
TCSNT Confocal system (Leica). Using a 63x water corrected PL APO lens, a single 
scan was taken through the centre of each follicle as determined by central positioning 
of the propidium iodide stained germinal vesicle in the oocyte (if the oocyte was not 
visible, the largest cross-section was used). Simultaneous scans at 488 nm (the green 
channel which shows any TUNEL labelled DNA) and 568 nm (the red channel which 
shows propidium iodide stained nuclear material) were taken. The number of TUNIEL 
labelled cells (granulosa and theca) and the total number of cells in each section were 
counted. Due to substantial loss of theca cells in groups treated with serum, the effect 
of ascorbic acid on theca cell death was analysed in the serum-free groups only. 
5.2.5. Detection of MMP-2 and MMP-9 in Culture Medium 
Gelatinase activity was detected in serum-free medium (n=24) on Day 8 of culture as 
described in 4.2.4. 1. MMP activities as detected by zymography were measured by 
transmission densitometry (G-700 Densitometer; BioRad). Relative intensities were 
derived from zymogram gels by comparison to parallel background readings of equal 
area and calculated using dedicated software (Quantity One; BioRad). Densitometric 
readings were only compared with another gel examined under precisely same 




5.2.6. Detection of Oestradiol in Culture Medium 
Concentrations of oestradiol in unextracted serum-free culture media from follicles 
cultured with (Day, 2, 4, 6, 8, 10, 12: n=42, 35, 17, 31, 41, 39) or without (Day, 2, 4, 
6, 8, 10, 12: n=45, 30, 28, 36, 32, 34) ascorbic acid were determined every second 
day of culture by radioimmunoassay, as described in 3.2.3. The sensitivity of the assay 
was 36 pg/mi. The intra- and inter-assay coefficients of variation were 4.0% and 
4.8%, respectively. 
5.2.7. Statistical Analyses 
Mean percentage increase in follicle diameter in the 6 experimental groups on Day 8, 
and the four experimental groups on Day 12 were compared using a one-way 
ANOVA, with subsequent t-tests to allow for individual comparisons between groups. 
Within each group, correlations were obtained between percentage increase in follicle 
diameter and the percentage of follicles which remained intact during culture. In 
addition, the proportion of follicles remaining intact on every second day of culture 
were compared using a 2-proportions test. Follicles fixed for histological assessment 
on Day 6 were analysed for differences in the % of follicles containing degenerate 
granulosa cells (as assessed as having >5% pyknotic nuclei) by a 2-proportions test. 
In addition, oocyte degeneration on Day 6 and Day 12 in follicles cultured with 
ascorbic acid was assessed by a 2-proportions test. Follicles cultured for 12 days were 
assessed for granulosa and theca cell death by TUNEL. The percentage of labelled 
granulosa cells were compared between the four groups by ANOVA. In addition, the 
number of labelled granulosa cells as a proportion of the total number of cells in each 
treatment group were compared using chi-square analysis. The effect of ascorbic acid 
on theca cell death was analysed in the serum-free groups using a 2-sample (-test. The 
number of healthy oocytes as a proportion of the total number of oocytes analysed in 
ascorbic acid-treated follicles on Day 6 and Day 12 of culture were compared using a 
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2-proportions test. Oestradiol secretion was measured in serum-free control and 
ascorbic acid-treated follicles and values compared using ANOVA and subsequent 2-




5.3.1. Follicular Growth 
Follicles were cultured for 12 days in the presence (n=82) or absence (n=8 1) of 
ascorbic acid in serum-free medium. In addition, follicles were cultured in the 
presence ofFBS which was added on Day 0 (n40) or Day 6 (n=66) of culture in the 
presence or absence of ascorbic acid. There was significant follicle growth in all 
treatment groups (p< 0.01) (Figure 5.2). Follicle cultures containing serum from Day 
0 were terminated at Day 10 due to an increased occurrence of follicle rupture. As a 
result of follicle loss in these groups, only measurements up until Day 8 of culture 
were used for measurement of follicle growth (Figure 5.2b). On Day 8 there was a 
significant difference in percentage follicle growth between all treatment groups (p< 
0.05). Follicles cultured in serum (with and without ascorbic acid) from the start of 
culture had a higher percentage increase in follicle diameter than serum-free controls 
by Day 8 (p< 0.05). However, serum alone did not significantly increase percentage 
increase in follicle diameter compared to follicles treated with ascorbic acid in serum-
free medium. When FBS was added to follicles on Day 6, there was no difference in 
percentage follicle growth by Day 12 compared to control or ascorbic acid-treated 
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Figure 5.2. (a) Effect of ascorbic acid on follicular growth. Ascorbic acid 
(squares, n =82), Control (circles, n=81). 
(b) Effect of serum on follicular growth. FBS added Day 0 (closed circles, 
n=20), FIBS added Day 6 (squares, n=33), Ascorbic acid with FBS added Day 0 (open 
circles, n=20), Ascorbic acid with FBS added Day 6 (triangles, n=33). Values are 
mean ± SEM. n represents the number of follicles in each treatment group at the 
beginning of culture. 
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5.3.2. Follicular Integrity 
There was a negative correlation (p< 0.05) between percentage follicle growth (as 
described above) and the percentage of follicles remaining intact during the 12 day 
culture period. For follicles cultured for 10 days, there was a significant correlation 
only in the absence of ascorbic acid. (p< 0.05). As illustrated in Figure 5.3, from Day 8 
of culture onwards, significantly (p< 0.05) more ascorbic acid-treated follicles 
remained intact in the absence of serum compared to control follicles and follicles 
treated with serum from Day 0. After 10 days, follicles treated with serum from Day 0 
had a significantly greater loss of basement membrane integrity than follicles in all 
other treatment groups (p< 0.05). By Day 12, a higher proportion of follicles had 
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Figure 5.3. (a) Effect of ascorbic acid on follicular integrity. Ascorbic acid 
(red bars, n=82), Control (blue bars, n=8 I). 
(b) Effect of serum on follicular integrity. Ascorbic acid with FBS added Day 
6 (yellow bars, n=33), FBS added Day 6 (blue bars, n=33), Ascorbic acid with FBS 
added Day 0 (green bars, n=20), FBS added Day 0 (red bars, n=20). n represents the 
number of follicles in each treatment group at the beginning of culture. 
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5.3.3. Histological Assessment 
Histological observations were made on control follicles on Day 6 (n=22) and on 
ascorbic acid-treated follicles in serum-free medium on Day 6 (n=10) and Day 12 
(n=1 1) of culture. Granulosa cell degeneration (expressed as % of follicles with >5% 
pyknotic nuclei) was greater in control follicles than in ascorbic acid-treated follicles 
on Day 6 of culture (p< 0.05) (Table 5.1). However, the number of degenerate 
oocytes was significantly higher on Day 12 than on Day 6 in ascorbic acid-treated 
follicles (p< 0.001) (Table 5.2). Examples of a follicle with healthy and degenerate 
oocytes are shown in Figure 5.4. 
Table 5.1. Effect of ascorbic acid on the percentage of follicles with 
pyknotic granulosa on Day 6 of culture 
Treatment 	Granulosa Degeneration 
(% Follicles) 
Control' 	 18.2 
Ascorbic Acid Oc 
afl=22,  '°n=10, 'Significantly lower than control (p<  0.05). 
Table 5.2. Oocyte health on Day 6 and Day 12 of culture in the presence 
of ascorbic acid 
Treatment Oocyte Degeneration 
(% Follicles) 
Day 6a 	 30 
Day 12b 909C 
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Figure 5.4. Histological sections representing healthy and degenerating 
oocytes. (a) (i) a healthy follicle with (ii) a healthy oocyte, (b) an unhealthy oocyte 
showing detachment from the granulosa cells. Bar = 20 pm. 
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5.3.4. Detection of Apoptosis by TUNEL 
Freshly isolated follicles (Day 0; n=8), and follicles cultured for 12 days (control, n=9; 
ascorbic acid, n=9; serum added Day 6, n=8; ascorbic acid with serum added Day 6, 
n=9) were stained for the occurrence of cell death by TUNEL. The follicle sections 
containing the oocyte germinal vesicle were analysed using confocal microscopy and 
image analysis. The occurrence of cell death in the granulosa compartment was 
significantly different between all treatment groups (p< 0.05) (Table 5.3). There was 
no granulosa cell death in freshly isolated follicles or those cultured with ascorbic acid 
(with or without serum). There was significantly (p< 0.001) more granulosa cell death 
in control follicles and serum-treated control follicles than in day zero follicles or in 
follicles treated with ascorbic acid alone. Follicles treated with serum had healthier 
granulosa cells when ascorbic acid was also present (p< 0.001). In addition, follicles 
cultured with ascorbic acid displayed a significantly (p< 0.01) lower incidence of 
theca cell death than controls (Figure 5.5). Examples of a follicle with healthy 
granulosa cells and a follicle undergoing granulosa cell death are shown in Figure 5.6. 
86 
Chapter 5 
Table 5.3. Effect of ascorbic acid and serum on granulosa cell 
apoptosis on Day 12 of culture 
Treatment 	 Apoptotic Granulosa 
Cells (mean % ± SEM)a 
Day 	 0±0 
Control (Day 12) 	 6.44 ± 323b 
Ascorbic Acid (Day 12) 	0 ± 0 
FBS (Day 12) 	 12.43 ±4.l3b 
Ascorbic Acid + FBS (Day 12) 0 ± 0 















Figure 5.5. Effect of ascorbic acid on theca cell apoptosis. Expressed as 




Figure 5.6. Detection of apoptosis by TUNEL 
(a) ascorbic acid-treated follicle on Day 12 of culture: (i) Follicle stained with 
propidium iodide (red), (ii) Apoptotic theca cells labelled with fluorescein dUTP 
(green), no apoptotic granulosa cells present. (b) Control follicle on Day 12 of 
culture: (i) Follicle stained with propidium iodide (red), (ii) Apoptotic mural 
granulosa cells and theca cells labelled with fluorescein dUTP (green). Bar = 100 
jim. 
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5.3.5. Oestradiol Secretion 
During the 12 day culture period, there was significant (p< 0.01) oestradiol secretion 
by follicles in serum-free medium in the presence and absence of ascorbic acid (Figure 
5.7). No significant differences in oestradiol secretion between ascorbic acid and 
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Figure 5.7. Effect of ascorbic acid on oestradiol secretion. Follicles were 
cultured in the presence (open circles) or absence (closed circles) of ascorbic acid. 
Values are mean ± SEM. 
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5.3.6. MMP-2 and MMP-9 Secretion 
Ascorbic acid-treated (n= 12) and control medium (n= 12) from Day 8 of culture were 
analysed for MW activity. MMP-2 (72 kDa) and MIvIP-9 (92 kDa) were detected in 
all samples. Densitometric analysis showed that latent MTvIP-9 activity was 
significantly higher in conditioned medium from ascorbic acid-treated follicles (p< 
0.05). ). The densitometric readings, taken within the range of linear sensitivity of the 
zymogram gel, represent a 1.5 fold increase (3748 to 5784 densitometric units) in 
enzyme activity. An example of a zymogram demonstrating MMP-2 and MAP-9 
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Figure 5.8. (a) Representative gelatin zymography gels showing gelatinase 
activities in conditioned medium collected from bovine follicles maintained in culture 
for eight days, either untreated (control) or treated with ascorbic acid. Gelatinase 
activities corresponding to the latent forms of MMP-2 and MMP-9 are indicated. A 
sample of human amniotic fluid collected at term was used as a positive control (af). 
Molecular weight markers (mw) are as indicated (kDa). 
(b) Densitometric analysis (expressed as relative densitometric units; mean ± SEM; 
n=12) of the gelatinase activities of the latent forms of MMP-2 and MMP-9 in 
conditioned medium collected from bovine follicles after 8 days in culture, with no 
treatment (control) or treated with ascorbic acid. * significantly (p< 0.05) greater 




The results presented here demonstrate successful growth and differentiation of 
bovine preantral follicles over 12 days in a serum-free culture system. We have also 
shown that ascorbic acid maintains follicle integrity in the absence of serum 
throughout the culture period, reduces the incidence of apoptotic cell death, and may 
participate in the regulation of remodelling of the extracellular matrix. 
Ideally, a long term culture system would be serum-free in order to allow the 
definition of optimal conditions for follicle development. Replacement of serum with 
ascorbic acid in our culture system did not significantly increase follicle growth, but it 
did allow the follicles to maintain their morphology throughout the culture period.. We 
have determined that increased rate of follicle growth correlates with significantly 
decreased follicle integrity during the 12 day culture period. The presence of serum in 
culture medium may have accelerated follicle development at a rate which could not 
be sustained, which led to follicle rupture. In addition, there was substantial theca cell 
loss from follicles in serum-treated groups (results not shown). 
Little is known of the regulators of follicle growth during the gonadotrophin-
independent stages of development. Early evidence for the role of ascorbic acid has 
come from the use of scorbutic guinea pigs (Kramer etal., 1933), which are infertile 
due to ascorbic acid deficiency and demonstrate degeneration in the follicle wall 
consistent with loss of basement membrane integrity (Kramer et al., 1933). Although 
little is known of the role of ascorbic acid in facilitation of follicle expansion in the 
growth phase, depletion of ascorbic acid is associated with structural involution in the 
corpus luteum in conjunction with increased activity of matrix-degrading enzymes 
(Endo et al., 1993). Ascorbic acid, acting as an antioxidant, has been implicated in 
collagen biosynthesis (Pinnell, 1985), which is essential for basement membrane 
construction during follicle growth. 
Regulated degradation of the ECM may provide an important mechanism for 
regulation of growth factor availability and activity during follicle development 
(Mclntush and Smith, 1998). With respect to the preantral and early antral stages of 
follicular development, the contribution of the various MIMPs and associated 
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regulators to follicular remodelling is not well understood. Work described in the 
previous chapter demonstrated that secretion of MIvIP-9 and TIIv1P- I and -2 from 
bovine preantral follicles during culture is indicative of follicle health at 6 days. In the 
current study, MMP-2 and -9 are secreted by follicles on Day 8 of culture in the 
presence and absence of ascorbic acid. This indicates that the majority of follicles are 
able to proceed to this stage and remain healthy in basic serum-free culture medium. 
However, some control follicles were found to have pyknotic granulosa cells on Day 
6 of culture, whereas in the presence of ascorbic acid, these were not detected. From 
Day 8 onwards there was an increased loss of basement membrane integrity in the 
absence of ascorbic acid, and by Day 12 there is an increase in apoptotic cell death in 
these groups. Our results are in agreement with other in vitro studies (Rose et al., 
1999; Murray etal., 2001), which have demonstrated promotion of follicle integrity 
and survival by ascorbic acid in cultured mouse follicles. The study by Murray et al. 
(2001) also reported an increase in MMP and TIMP activity in the presence of 
ascorbic acid. 
The zymography results presented here emphasise the usefulness of IvilvIP 
detection as a means of monitoring follicle health throughout culture. This is 
illustrated by the finding that granulosa cell death (as assessed by the level of 
pyknosis) was detected in control follicles on Day 6 of culture, but not in the presence 
of ascorbic acid; and subsequently (on Day 8 of culture) the level of MIIvIP-9 was 
found to be lower in medium from control follicles than in ascorbic acid-treated 
groups. Therefore, as ascorbic acid increased MIIVIP-9 activity, there may be a role for 
ascorbic acid both in the regulation of ECM turnover and in the maintenance of 
follicle health during long-term culture. In the previous chapter, the importance of 
maintaining healthy theca cells and their connections with the granulosa layers in 
bovine follicle culture was emphasised, and a role for these cell types in basement 
membrane remodelling during the early stages of folliculogenesis was proposed. 
However, other studies have reported follicle rupture or loss of theca cells from 
bovine preantral follicles during culture (Ralph, 1996; Gutierrez et al., 2000). As we 
have shown here that ascorbic acid significantly reduces theca cell death in vitro, this 
may help to overcome these problems and facilitate normal folliculogenesis in vitro. 
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In order to maintain health and normal development of the oocyte in vitro, it is 
important to define conditions which are conducive to somatic cell survival. The role 
of ascorbic acid in the neutralisation of free radical species has been well studied. As 
well as having relevance to follicle remodelling, this action of ascorbic acid affects the 
process of follicular cell death. Tilly and Tilly (1995) reported that accumulation of 
free radical species in tropic-factor deprived follicles is involved in triggering 
granulosa cell apoptosis. In that study, FSH suppressed apoptosis in cultured rat 
antral follicles, and this effect was mimicked by antioxidants including ascorbic acid. 
In our culture system, follicles treated with ascorbic acid had a significantly lower 
incidence of apoptotic cell death in granulosa and theca cells compared to control 
follicles in serum-free medium. However, the histological data shows that oocyte 
health declined between Day 6 and 12 of culture. This indicates that although the 
culture conditions are sufficient for maintenance of granulosa cell health, more 
research is required to identify factors which will be beneficial to oocyte development 
in vitro. Interestingly, when serum was added to follicles on Day 6 of culture, follicles 
had significantly more apoptotic granulosa cells by Day 12 than controls or ascorbic 
acid-treated follicles. However, this effect was not apparent when serum was added in 
conjunction with ascorbic acid. As more follicles were found to lose basement 
membrane integrity when serum was present, any deleterious effects may be due to 
inappropriate stimulation of follicles by serum during the early stages of development. 
Alternatively, serum factors may have a direct negative effect on immature follicles in 
culture. 
Ascorbic acid had no significant effect on the production of oestradiol by 
follicles during the culture period. This finding is in agreement with a study using 
cultured mouse follicles (Murray et al., 2001). Ascorbic acid is thought to play a 
similar role in steroidogenesis in the ovary as in the adrenal gland, where high 
concentrations inhibit steroid biosynthesis through inhibition of hydroxylation systems 
(Kitabchi, 1967). However, the precise mechanism through which this is effected is 
not well understood. Since ascorbic acid uptake in granulosa cells is positively 
regulated by FSH and IGF- 1 in a synergistic manner similar to the control of 
granulosa cell differentiation (Giudice, 1992; Behrman etal., 1996) ascorbic acid may 
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play an important part in expansion, survival and steroidogenesis in the later stages of 
folliculogenesis and during the establishment of dominance. 
In conclusion, we have shown that ascorbic acid improves the survival of 
follicles in a serum-free culture system, and reduces somatic cell death. In addition, 
we have reported a role for ascorbic acid in the regulation of basement membrane 
remodelling by influencing MMP production. Ascorbic acid had no effect on 
oestradiol production or follicle growth in this study. As oocyte health was found to 
decline during the culture period, further investigation is required in order to identify 
factors necessary for improvement of oocyte quality in vitro. In chapter 6, we will 
discuss a putative role for IGF- 1 in the regulation of oocyte development in vitro. 
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As discussed in previous chapters, IGFs are important regulators of follicular 
function. However, there appears to be differential regulation of these factors 
according to developmental stage, as well as species differences regarding spatial and 
temporal action. 
The bioactivity of IGFs is controlled by their association with a family of 
specific IGF binding proteins (IGFBPs), which are found in association with the 
extracellular matrix (ECM) and cell membranes. In many mammalian species, 
follicular growth and atresia are characterised by dramatic changes in follicular IGFBP 
levels (e.g. sheep: Monget et at., 1993; cow: Echternkamp etal., 1994; pig: Grimes et 
al., 1994; human: Cataldo and Giudice, 1992). Since IGFBPs have equal or higher 
affinity for IGFs than do IGF receptors (Shimasaki etal., 1991), the degradation of 
IGFBPs by specific IGFBP-degrading proteinases may be an important step in 
regulating the actions of IGFs (Fowikes et al., 1995). 
The IGF-1 analogue LR3 IGF-1, which does not bind to IGF binding proteins, 
is widely used in follicle and granulosa cell culture systems. Recently, this factor was 
reported to increase growth of bovine preantral follicles in a long term culture 
(Gutierrez el al., 2000). We reported in chapter 3 that this IGF- 1 analogue does not 
increase follicular growth during a six day culture period, and have hypothesised that 
the follicles may not have differentiated sufficiently in vitro to respond appropriately 
to this potent form of IGF- 1. In the current chapter we will determine whether LR3 
IGF-1 has any effects on the proliferation and morphology of the follicles cultured in 
experiments described in chapter 3. Follicles cultured in the presence of recombinant 
IGF- 1 will also be examined using histological and immunocytochemical methods, in 
order to determine whether allowing IGF-1 to be sequestered by IGFBPs has any 
effect on the development of the oocyte and follicular cells. 
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6.2. MATERIALS AND METHODS 
6.2.1. Follicle Isolation and Culture 
Preantral follicles (100-200 p.m) were dissected from bovine ovaries and cultured for 
6 days as described in chapter 2. 
6.2.2. Treatments 
6.2.2.1. Treatment with LR3 IGF-1 in the absence of ascorbic acid 
Follicles were cultured for 6 days in control medium (n=6 1) or in the presence of 10. 
ng/ml LR3 IGF-1 (n= 72), as described in 3.2.2.1(a). 
6.2.2.2. Treatment with recombinant IGF-1 and LR3 IGF-1 in the presence of 
ascorbic acid 
Follicles were cultured in control medium (n=79) or in the presence of 10 nglml 
recombinant IGF-1 (n80) or LR3 IGF-1 (n=79), as described in 3.2.2.3. 
6.2.3. Histological Assessment 
Follicles were processed for histological analysis as described in chapter 2. 
6.2.4. Detection of Granulosa Cell Proliferation by Immunocytochemistry 
At the end of the culture period, follicles were fixed in 4% paraformaldehyde, 
processed and mounted as described in 2.3.3. Sections (Control: n10, LR3 IGF-1: 
n=12, hrIGF-1: n=13) were assessed for cell proliferation using a Ki67 antigen 
detection kit as described in 2.3.3.3. 
98 
Chapter 6 
6.2.5. Statistical Analyses 
Oocyte diameters from freshly isolated and cultured preantral follicles were compared 
using a one-way ANOVA, with subsequent t-tests to allow individual comparisons 
between groups. Oocyte diameters are also represented graphically using box and 
whisker plots. In experiment 6.2.2.1, the number of follicular granulosa layers present 
at the end of culture was compared between groups using a Chi-square test. In 
experiment 6.2.2.2, the mean percentage of proliferating cells on Day 6 of culture was 




6.3.1. Histological Assessment 
6.3.1.1. Effect of LR3 IGF-1 in the absence of ascorbic acid 
Histological observations were made using freshly isolated follicles (n=10), LR3 IGF-
1 treated follicles (n=24) and control follicles (n22). A significant difference in 
oocyte diameter between the three groups was detected by ANOVA (p< 0.01), and 
follicles treated with LR3 IGF-1 had significantly smaller oocytes than controls and 
freshly isolated follicles (p< 0.01) (Figure 6.1). Follicles cultured with LR3 IGF-1 also 
had a reduced number of granulosa cell layers (p< 0.01) by day 6 of culture (Table 
6.1). However, LR3 IGF-1 had no effect on the percentage of follicles with 
degenerating oocytes and granulosa cells, the thickness and level of pyknosis of the 
follicular theca layers, nor on the percentage of follicles which formed an early antrum 
in vitro (Table6.1). Examples of follicles with healthy and degenerating somatic cells 
are shown in Figure 4.3. 
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Table 6.1. Effect of LR3 IGF-1 on histological measurements on Day 6 of culture 
Treatment 	Mean Oocyte Mean No. Mean No. Oocyte - Granulosa Theca Antrum Formation 
Diameter (jim Granulosa Theca Layers Degeneration Degeneration Degeneration (% Follicles) 
± SEM)a Layers (± SEM) (± SEM) (% Follicles) (%.Follicles) (% Follicles) 
Contro lb 	52.4 ± 3.60 9.3 ± 0.41 3.9 ± 0.53 18.2 18.2 47.4 40.1 
LR3 IGF1c 	37 . 8±2 . 34d 6 . 4±0 . 3Od 3.0±0.44 37.5 16.7 58.8 33.3 
a SEM = standard error of the mean. 
b  n = 22 
n = 24 
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Figure 6.1. Effect of LR3 IGF-1 on oocyte diameter. Box and whisker plot of 
histological measurements of mean oocyte diameter on Day 0 and Day 6 of culture. n 
represents the total number of follicles analysed for each treatment. Box represents 
the median and the upper and lower quartiles. Whiskers illustrate the expected data 
range (* denotes outlier). Different letters indicate significant differences (p< 0.01). 
102 
Chapter 6 
6.3.1.2. Effect of recombinant IGF-1 and LR3 IGF-1 on oocyte diameter 
Histological observations were made using freshly isolated follicles (n16), LR3 IGF-
1 treated follicles (n= 17), recombinant IGF- 1 treated follicles (n= 16) and control 
follicles (n=18) on day 6 of culture. Oocyte diameters are represented in Figure 6.2. A 
significant difference in oocyte diameter between the three groups was detected by 
ANOVA (p< 0. 05). Only follicles treated with recombinant IGF-1 had significant 
oocyte growth compared to day zero oocytes. (p< 0.01). In addition, follicles treated 
with LR3 IGF- 1 had significantly smaller oocytes than recombinant IGF- 1 treated 
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Figure 6.2. Effect of LR3 IGF-1 and recombinant IGF-1 on oocyte 
diameter. Box and whisker plot of histological measurements of mean oocyte 
diameter on Days 0 and 6 of culture. n represents the total number of follicles 
analysed for each treatment. Box represents the median and the upper and lower 
quartiles. Whiskers illustrate the expected data range (* denotes outlier). Oocyte 
growth is significant from day 0 to day 6 only in the presence of recombinant IGF-1 
(Rec IGF-l) (p< 0.01). 
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6.3.2. Detection of Granulosa Cell Proliferation 
As illustrated in Table 6.2, there was a significant difference in the percentage of 
Ki67-positive granulosa cells between groups on Day 6 of culture (p< 0.05). There 
was significantly more proliferation in LR3 IGF- 1 follicles (n=12) and recombinant 
IGF-1 (n=13) follicles than in controls (n10) (p< 0.05). There was no difference in 
the percentage of proliferating cells between the two IGF-1 groups. A follicle 
displaying Ki67-positive staining is displayed in Figure 6.3. 
Table 6.2. Effect of IGF-1 on granulosa cell proliferation on Day 6 of 
culture 
- Treatment Proliferating 
Granulosa Cells 
(mean % ± SEM) 
Control 8.04±2.45 
Recombinant IGF-1 16.63 ± 2.82a 
LR3 IGF-1 18.43 ±3.16a 













Figure 6.3. Detection of proliferation by K167 immunostaining. (a) Follicle 
showing Ki67-positive staining (dark brown) in granulosa cells. (b) Negative control 
follicle. Bar = 50 m. 
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6.4. DISCUSSION 
The results presented here demonstrate a significant effect of recombinant IGF- 1 and 
the analogue LR3 IGF- 1 on follicle proliferation in bovine preantral follicles cultured 
for 6 days in a serum-free system. In the initial experiment, we demonstrated that LR3 
IGF- 1 exerts a negative effect on oocyte development and the number of granulosa 
cell layers during preantral and early antral stages of folliculogenesis. Subsequently, 
we confirmed that LR3 IGF- 1 adversely affects oocyte growth in vitro. In addition, 
we determined that recombinant IGF- 1, which associates with IGFBPs, does not 
produce this deleterious effect. 
Within bovine antral follicles, there is evidence of a complete intrafollicular 
IGF system (Armstrong etal., 1998, 2000) in which follicles express IGF ligand, and 
mediation of IGF action and bioavailability occurs through receptors and binding 
proteins. The expression of mRNA encoding IGF- 1 is developmentally regulated in a 
species-specific manner (Armstrong and Webb, 1997; Webb and Armstrong, 1998). 
As discussed in chapter 3, immunoreactive type 1 IGF receptor has been 
visualised in oocytes and granulosa cells of primordial, preantral and antral human 
follicles (Qu et al., 2000) which implies a role for IGFs during early follicle and 
oocyte development. We have shown here that recombinant IGF-1 and LR3 IGF-1 
stimulate proliferation of preantral follicles. However, the precise role of IGFs in 
regulation of oocyte development during early folliculogenesis is unclear. IGF- 1 
stimulates nuclear maturation of cumulus-enclosed oocytes (Gomez etal., 1993; 
Yoshimura et al., 1996; Pawshe etal., 1998), and improves early embryonic 
development (Pawshe etal., 1998). Moreover, IGF-1 knockout mice have reduced 
glucose transporter expression, which is thought to be essential for oocyte maturation 
and successful ovulation (Zhou el al., 2000). Since 'maternal' factors which 
accumulate in the oocyte may have a long lasting effect on subsequent development 
(Revel et al., 1995), IGF-1 may exert an effect on oocyte maturation in early follicle 




We have demonstrated here that treatment of immature follicles with LR3 
IGF- 1 adversely affects oocyte growth. In vivo, IGFBPs control IGF bioactivity by 
regulating its availability to IGF receptors (Jones and Clemmons, 1995). For example, 
IGFBP- 1 has been shown to inhibit the synergistic effect of IGF- 1 and FSH in 
stimulating progesterone production by cultured rat granulosa cells (Bicsak et al., 
1990). In addition, IGFBP-3, which is expressed in bovine theca cells (Webb el al., 
1999), has been shown to inhibit the ability of IGF- 1 to stimulate proliferation, 
progesterone and androstenedione production by bovine theca cells (Spicer et al., 
1997). Furthermore, during bovine follicular growth and atresia, there are distinct 
spatial and temporal changes in the expression of IGFBP-2 and —4 mRNA in vivo 
(Armstrong et al., 1998). 
Interestingly, the presence of the Booroola (Fecundity) gene in sheep, 
characterised by increased ovulation rate (Davis et al., 1982) and precocious follicular 
maturation (Henderson etal., 1985; McNatty etal., 1986), correlates with reduced 
intrafollicular IGFBP concentrations compared with follicles from sheep which do not 
carry the mutation (Monniaux etal., 2000). The increased availability of IGF at an 
earlier stage may, at least in part, have an effect on the acquisition of oocyte meiotic 
competence thus leading to increased ovulation rate in these animals. During early 
antral development in bovine follicles, IGFBP-2 from the granulosa cells may regulate 
the bioavailability of IGFs (Armstrong etal., 1998). At the appropriate stage of 
development, specific IGFBP proteinases release bound IGFs, thus allowing IGF to 
act upon on the follicle or oocyte (Logan and Hill, 1992). The origin and regulation of 
intrafollicular proteinase(s) degrading IGFBPs in the ovary are still unclear. Calcium 
and zinc-dependent metalloproteinases may be involved in porcine intrafollicular 
IGFBP proteolytic activity (Besnard et al., 1997). However, experiments using a 
synthetic MIVIIP inhibitor determined that 60, 70 and 72 kDa MIVIIPs are not of primary 
importance in the degradation of intrafollicular IGFBPs < 40 kDa (IGFBP-2, -4 and - 
5) in the pig (Besnard et al., 1997). 
As LR3 IGF- 1 does not bind to IGFBPs, we have previously suggested that 
over-stimulation of immature follicles by this IGF- 1 analogue may lead to precocious 
differentiation which impedes oocyte development. In the current chapter we have 
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shown that regulation of the bioavailability of IGF- I by IGFBPs promotes oocyte 
growth in vitro. If MItvlPs are involved in facilitation of this action of IGF- I on the 
oocyte, these enzymes may also be useful markers for oocyte development in vitro. 
In conclusion, we have investigated the effects of IGF-1 on bovine preantral 
follicle development in a serum-free culture system, and shown that recombinant IGF -
1 and the analogue LR3 IGF-1 stimulated follicle proliferation during a six day culture 
period. However, LR3 IGF- 1 had a damaging effect on oocyte development at the 
preantral and early antral stages, whereas recombinant IGF- 1 promoted oocyte 
growth in vitro. These experiments highlight the importance of the IGF system in the 
early stages of follicle development, and emphasise the need for preserving 
physiological control mechanisms during follicle culture. These results also suggest 
that it may be necessary to dissociate oocyte and somatic cell requirements in order to 





7.1. General Discussion 
An abundant and homogeneous source of oocytes for use in In vitro maturation 
(IVM) systems could be obtained by growing oocytes from preantral follicles in vitro. 
However, culture systems for bovine and ovine follicles have not been successful in 
terms of producing meiotically competent oocytes (reviews: Telfer, 1998b; Telfer et 
al., 2000). In order to advance this technology, recent culture systems have 
concentrated on defining conditions for the early stages of follicle development 
(Figueiredo et al., 1994; Hulshofet al., 1995; Cecconi eta!, 1999). 
The aims of this thesis were (I) to investigate factors affecting early bovine 
follicular development using a defined culture system, and (II) to identify markers of 
early follicular development in vitro. The main findings from thi's study, alongside 
information from other researchers, are illustrated in Figure 7.1. The identified 
factors may, at specific stages of development, play a significant role in bovine follicle 
and oocyte development in vitro. 
Ovarian folliculogenesis is regulated by both endocrine and intraovarian 
mechanisms which co-ordinate the processes of somatic cell proliferation and 
differentiation. As discussed in chapter 1, regulation occurs at various levels, with a 
constantly shifting contribution by endocrine, autocrine and paracrine factors. 
Furthermore, the oocyte may participate in the control of its own development as well 
as that of the follicular cells. Evidence from studies in domestic ruminants shows that 
locally produced growth factors together with receptors for both growth factors and 
gonadotrophins are expressed during early follicle development in a stage- and cell-
specific manner (review: McNatty et al., 1999). In chapter 3, preliminary experiments 
determined that bovine preantral follicles are capable of growth and differentiation (as 
measured by oestradiol secretion and antrum formation) during a six day serum-free 
culture period. FSH and IGF-1 did not significantly increase follicular diameter, 
although FSH was found to stimulate follicular oestradiol secretion. Hence FSH is 
probably affecting granulosa cell differentiation in this system. The dissociation of 
follicular growth from steroidogenenic function indicates that measurement of 
follicular diameter may not be a reliable marker of physiological follicular 
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development in vitro. Subsequent chapters proceeded to further investigate follicle 
and oocyte development during the early stages of folliculogenesis. Furthermore, 
rather than relying on follicle growth as a indicator of follicle development, follicle 
and oocyte morphology were examined in vitro. 
It is becoming increasingly clear that the follicular ECM plays an important 
part in many of the regulatory processes during folliculogenesis. For example, 
numerous in vitro studies have shown that cell morphology is altered according to the 
type of ECM component on which the cells are cultured (Watt, 1986). In addition, the 
follicular basal lamina is believed to play a role in influencing granulosa cell 
proliferation and differentiation (Amsterdam et al., 1989; Richardson etal., 1992; 
Luck, 1994). During follicular development, turnover and reconstruction of the 
follicular ECM is facilitated and regulated by matrix metalloproteinases (MMPs) and 
tissue inhibitors of metalloproteinases (TIMPs). In chapter 4, secretion of MfvlPs and 
TIMPs from preantral follicles during a six day culture period was measured. It was 
demonstrated that when MIMP-9 and TIIMPs are secreted in vitro, a follicle has a 
higher probability of being healthy at the end of the culture period. If oocyte 
development is to occur in species with a long growth period, an extended culture 
period will be necessary. Therefore, non-invasive markers of follicular development 
are required. Since MrvlIPs and TIMPs can be detected in conditioned culture medium, 
these factors are candidates for this role. 
The experiments described in chapter 3 and chapter 6 determined that IGF- 1 
increased granulosa cell proliferation in preantral follicles during a six day culture. 
However, LR3 IGF- 1, an analogue which does not bind to IGF binding proteins, was 
found to have a detrimental effect on oocyte development, whereas recombinant IGF-
1 promoted oocyte growth in vitro. These experiments highlight the importance of the 
IGF system in the early stages of oocyte development, and emphasise the need for 
preserving physiological control mechanisms during follicle culture. 
Growth factors influence follicular development, in part, by stimulating DNA 
synthesis and by modulating the onset of apoptosis in granulosa cells. For example, 
both IGF- 1 and EGF exert inhibitory influences on apoptosis in various cell types 
including granulosa cells (Tilly et al., 1992; Luciano etal., 1994). IGF binding 
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proteins are important components of the ECM that can have a major influence on 
cellular responses to IGF-1 (review: Giudice, 1992). Proteolysis of the ECM is a key 
process in regulation of availability of IGF- 1 activity within developing follicles 
(Figure 7.1). MIIVIPs have been reported to function as IGFBP-degrading proteinases, 
both in vitro and in vivo (Fowlkes et al., 1994a; Fowikes et al., 1994b; Thrailkill el 
al., 1995). However, within the ovary, the origin and regulation of the IGFBP-specific 
proteinase(s) is unknown. A previous study in the rat indicated that the proteinase(s) 
may partly derive from granulosa cells (Liu et al., 1993). In contrast, IGFBP-specific 
proteolytic activity is produced by the theca and stroma of human ovaries (Mason et 
al., 1996). It is becoming increasingly apparent that the oocyte produces factors that 
affect follicular development and function (Dong et al., 1996). Therefore, a role for 
the oocyte in regulation of IGF action requires investigation. Furthermore, as we have 
already made some progress in identifying secreted markers of follicle health in vitro, 
identification of specific proteinase(s) which degrade IGFBPs should significantly 
advance our ability to monitor oocyte progress during long term culture. 
In order to maintain health and normal development of the oocyte in vitro, it is 
important to define conditions which are conducive to somatic cell survival. Ascorbic 
acid has been implicated in several processes associated with follicular development, 
including collagen biosynthesis, steroidogenesis and apoptosis (review: Luck et al., 
1995). The role of ascorbic acid in the neutralisation of free radical species has been 
well studied. As well as having relevance to follicular remodelling, this action of 
ascorbic acid affects the process of follicular cell death. It was determined in chapter 5 
that a higher proportion of follicles remained intact in the presence of ascorbic acid in 
serum-free conditions, with significantly less granulosa and theca cell death than 
control follicles. Moreover, ascorbic acid significantly increased production of MrvlP-
9, an enzyme involved in basement membrane remodelling and a marker for follicular 
health. Therefore, ascorbic acid may be a key factor for the maintenance of bovine 
follicular health and remodelling in vitro. It has also been shown that IGF-1 increases 
the uptake of ascorbic acid into granulosa cells in vitro (Giudice, 1992; Behrman et 
al. 1996) (Figure 7. 1), thus this factor may be involved in the process of IGF- 1-
stimulated follicular proliferation and oocyte development. 
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Figure 7.1. Summary of the putative developmentally-regulated factors involved in 
early bovine folliculogenesis. 
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7.2. Concluding Remarks 
The aim of this thesis was to use a serum-free culture system to identify regulators of 
early bovine follicle and oocyte development. As well as adding to our understanding 
of the co-ordination of oogenesis and folliculogenesis, this research has led to the 
improvement of culture conditions for bovine preantral follicles and has facilitated the 
identification of markers of follicular health in vitro. The ultimate measure of the 
success of the culture system will be to determine whether oocytes grown in vitro are 
capable of meiotic maturation and completion of developmental competence. A 
technique for obtaining a source of homogeneous mature oocytes from bovine ovaries 
would provide a model for in vitro maturation (IVM) and fertilisation (IVF) systems 
for human oocytes, as well as permitting investigations into postovulatory and 
embryonic development. 
Improvement of existing techniques for assisted reproduction and 
nuclear transfer could potentially revolutionise modern medicine. However, over the 
last decade there has been no real progress in applying these techniques to humans 
and animals with follicles that undergo a long growth period. Since folliculogenesis is 
a chain of many complex and precisely regulated events, gaining a better 
understanding of this process is key to the advancement of such technology. It is 
important to emphasise that although follicle culture systems are important research 
tools for understanding basic mechanisms of follicular development, much has still to 
be learned before this technology can be applied in a clinical or commercial setting. 
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ABSTRACT 
Satisfactory development of bovine follicles in vitro remains 
elusive. This study used a serum-free system to evaluate the ef-
fects of insulin-like growth factor-1 (IGF-1) on bovine preantral 
follicles in culture and to identify the activity of gelatinase ma-
trix metal loproteinases (MMP5) and their endogenous inhibitors 
(TIMPs) in vitro to assess their potential as markers of devel-
opment. Preantral follicles were cultured for 6 days in serum-
free medium containing insulin and IGF-1 (10 ng/ml). No dif-
ference was observed in follicular growth, health, or antrum for-
mation between IGF-1 -treated follicles and controls. However, 
IGF-i had a negative effect (P < 0.01) on oocyte size and gran. 
ulosa cell proliferation. When MMP-9 was secreted, the proba-
bility of follicles having healthy granulosa or theca cells at the 
end of the culture period was 0.85 and 0.60, respectively. If 
lIMP-i was released, the probability of follicles having healthy 
somatic cells was 0.79. When TIMP-2 was detected, the proba-
bility of granulosa and theca cell health was 0.78 and 0.67, re-
spectively. These results demonstrate no positive effects of IGF-
1 on bovine follicles in this system. Furthermore, MMP-9 and 
lIMPs are related to follicular health and, therefore, can be used 
as markers of follicular development. 
follicle, granulosa cells, ovary, theca cells 
INTRODUCTION 
The number of oocytes in the ovary at birth varies enor -
mously between species, ranging from tens of thousands in 
mice to millions in humans and domestic species [1]. Of 
these oocytes, less than 1% will eventually ovulate [2]. In 
cattle, procedures for in vitro maturation and fertilization 
have progressed substantially during the past decade, lad-
ing to increased availability of zygotes, embryos, and 
calves for breeding and research purposes [3].  However, 
this technology has limitations, because oocytes cannot be 
harvested from the large population of hormone-insensitive, 
preantral follicles. Development of a culture system that 
can support preantral and, eventually, primordial follicles 
to a stage at which the oocytes can be matured and fertil-
ized in vitro would help to provide large amounts of ho-
mogeneous oocytes. Such a system would also allow the 
identification of factors necessary for normal follicular de-
velopment and acquisition of oocyte developmental com-
petence. 
Culture systems developed for rodent follicles [4-8] 
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have led to the production of developmentally competen 
oocytes after culture of whole preantral follicles or theii 
granulosa-oocyte complexes. Advances have been madt 
in transferring aspects from the rodent models to develop 
culture systems for porcine preantral follicles [9],  but pro. 
gress with other domestic species has been much slower 
Recently, a culture system for sheep preantral follicles wa 
described [10] that achieved antrum formation and estra 
diol production and maintained healthy oocytes and cu 
mulus cells during a 6-day culture period. However, thi 
system failed to produce germ cells with high develop. 
mental potential. Similarly, for bovine follicles, cultur 
has been terminated long before the preovulatory stag 
was reached [11-14]. In cattle, large ovaries, less densel) 
packed follicles, fibrous stromal tissue, large follicle size 
and slow follicular growth have all played a role in de-
laying the development of successful isolation and culturt 
techniques. Recently, however, accelerated growth of bo-
vine preantral follicles to the antral stage has beer 
achieved over a period of as many as 28 days [11], witl 
FSH, epidermal growth factor (EGF), and insulin-likc 
growth factor-i (IGF- 1) having a positive effect on follic-
ular growth and development. 
Insulin-like growth factors, and particularly IGF- 1, havc 
been identified as being important paracrine regulators ol 
ovarian function. Previous studies have helped to determint 
the actions of IGFs in antral follicles, which are thought tc 
vary according to species and the interaction of gonadotro. 
pins [15]. For example, granulosa cells from bovine antra] 
follicles have increased proliferation and estradiol produc-
tion in response to IGF-1 [16]. However, the precise rolt 
of the IGF system during the earlier stages of folliculai 
development is poorly understood. 
Previously, culture systems for cattle preantral follicles 
have resulted in loss of theca cells [11, 13] or rupture ol 
the basement membrane [11] in some follicles. During fol-
licular growth, turnover and reconstruction of the basemeni 
membrane is facilitated by matrix metalloproteinase 
(MMP5), which are zinc- and calcium-dependent enzymes 
that can degrade the protein components of the extracellulai 
matrix [17]. The MMPs are regulated by tissue inhibitor' 
of metalloproteinases (TIMP5) and are also responsible foi 
reconstruction of the basement membrane at the time 01 
ovulation and during corpus luteum formation [18]. The 
MMPs involved in the breakdown of collagen IV (i.e., 
major constituent of the basement membrane) are the ge-
latinases MW-2 and MMP-9. The main follicular sources 
of MMPs and TIMPs are thought to be the granulosa anc 
theca cells [18, 19],  but TIMP protein has also been founc 
in oocytes [20]. 
The present study used a serum-free culture system [ill 
to investigate the effects of IGF- 1 on several aspects ol 
bovine preantral and early antral development in vitro. Jr 
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addition, secretion of MMPs and TIMPs by cultured folli-
cles was identified, and using morphological comparisons, 
these factors were assessed for use as markers of follicular 
development. 
MATERIALS AND METHODS 
Isolation of Preantral Follicles 
Bovine ovaries from random stages of the estrous cycle 
were obtained from an abattoir and transported at 25-30°C. 
Beneath a laminar flow hood, ovaries were rinsed with 70% 
alcohol, and fine slices of ovarian cortex were taken using 
a scalpel and placed in Liebovitz's medium (GIBCO BRL, 
Life Technologies Ltd., Paisley, Renfrewshire, UK) supple-
mented with sodium pyruvate (2 mM), glutamine (2 mM), 
BSA (3 mg/ml), penicillin G (75 pg/mi), and streptomycin 
(50 g/ml). All chemicals were from Sigma Chemicals 
(Poole, Dorset, UK) unless otherwise stated. In a petri dish 
under the dissecting microscope, preantral follicles (100-
200 pm) were isolated from the cortical slices using fine, 
25-gauge needles attached to syringe barrels. Follicles with 
an intact basement membrane and an even distribution of 
granulosa and theca layers were selected for culture. 
Culture of Preantral Follicles 
For the control group, preantral follicles were cultured 
individually in 96-well plates (Bibby Stenlin Ltd., Stone, 
Staffs, UK) in 250 pA of culture medium (McCoy's 5a me-
dium with bicarbonate [Sigma]) supplemented with Hepes 
(20 mM), BSA (0.1%), L-glutamlne (3 mM), penicillin (100 
NJ/ml), streptomycin (0.1 mg/ml), transferrin (2.5 jig/ml), 
selenium (4 ng/ml), androstenedione (10 -7 M) and insulin 
(10 ng/ml). For the treatment group, 10 ng/ml of the ana-
logue Long R3 IGF-1 (Gropep Pty Ltd., Adelaide, Austra-
lia), which does not bind to IGF-binding proteins, was add-
ed to the control medium. Plates were incubated for 6 days 
in a sterile, humidified air atmosphere with 5% CO2 at 
37°C. Follicular diameters were measured under the dissec-
tion microscope on Days 0, 2, 4, and 6. Half the medium 
was replaced every second day, and this conditioned me-
dium was stored at —20°C for subsequent MMP/TIMP 
analysis. 
Histological Assessment of Follicles 
At the end of the culture period, follicles were fixed 
overnight in Bouin's solution and dehydrated in ethanol. 
Absolute ethanol was replaced with cedar wood oil for a 
minimum of 24 h, and then the oil was cleared from the 
follicles using toluene for 30 mm. Follicles were embedded 
in paraffin wax (60°C), with changes every hour for 4 h to 
remove all traces of toluene. The samples were sectioned 
(6 urn), mounted on gelatin-coated slides, and then allowed 
to dry overnight at 37°C before staining with hematoxylin-
and-eosin. 
Histological measurements and observations were made 
under the light microscope with a crossed micrometer 
(Graticules Ltd., Tonbridge, Kent, UK). The section con-
taining the oocyte nucleolus or, if this was absent, the larg-
est cross-section of the oocyte was used for observations 
and measurements. Follicular and oocyte sizes were mea-
sured, and proliferation was assessed by counting the num-
ber of granulosa and theca cell layers. Granulosa cell death 
was measured by counting the number of pyknotic cells 
and then expressing them as a percentage of the total num-
ber of granulosa cells; atretic follicles were defined as being  
those with more than 5% pyknotic nuclei [21]. Theca cell 
health was assessed in two ways: by the level of pyknosis, 
as defined earlier; and by the number of layers present, with 
less than three layers indicating theca cell degeneration. 
Oocyte quality was assessed on a scale of 0-2, with 0 in-
dicating an absent or severely misshapen oocyte with no 
germinal vesicle and obviously degenerate, 1 indicating a 
misshapen oocyte, and 2 indicating a morphologically nor-
mal oocyte with an intact germinal vesicle. 
Detection of MMP-2 and MMP-9 Secretion by Gelatin 
Zymography 
The MMP-2 and MMP-9 activities were detected by 
gelatinase zymography according to the method described 
by Riley et al. [22]. In brief, 100-RI samples of culture 
medium were dialyzed against distilled H 20 in small tube-
0-dialyzers (Chemicon International, London, UK) before 
being lyophilized and reconstituted in 7.5 pA, 0.1% SDS 
in H20. Samples were separated by SDS-PAGE using 
7.5% gels containing 1 mg/ml gelatin on a minigel appa-
ratus (Bio-Rad, Hemel Hempstead, UK). Gels were 
washed (twice for 15 min in 2.5% (v/v) Triton X-100, and 
twice for 2 mm in lox Tris-buffered saline [TBS]), then 
incubated overnight at 37°C in digestion buffer (50 mM 
Tris; 0.2 M NaCl; 5 mM CaCl2, 1 M ZnC12 ; 0.02% [v/v] 
Brij-35) Gels were stained for 3 h at 23 °C with 0.5% 
Coomassie Blue R250 in 30% methanol/10% glacial ace-
tic acid in H 20 and then destained (staining solution with 
Coomassie Blue omitted). Destaining revealed white 
bands where gelatin was degraded by gelatinase activity. 
The MMP-2 and MMP-9 were identified by comparison 
with molecular weight markers and control standards of 
human amniotic fluid collected during labor at term [22]. 
Detection of TIMP- 1 and TIMP-2 Secretion by Reverse 
Zymography 
The TIMP activity was detected using a commercial kit 
(University Technologies Inc., Calgary, Canada) according 
to the method described by Riley et al. [22]. Samples were 
lyophilized and reconstituted as before and separated ac-
cording molecular weight by PAGE using 12% gels con-
taining gelatin (1 mg/ml) and a preparation of MIvIP-2 (con-
ditioned medium from BHK-21 cells that constitutively ex-
press MMP-2; University Technologies). The gels were 
washed (50 mM Tris, 5 mM CaC12 , 2.5% [vlv] Triton X-
100) for 2.5 h at 23°C, then incubated in digestion buffer 
(50 mM Tris, 5 mM CaCl2) overnight at 37°C. After stain-
ing and destaining (as in zymography), TIMPs were rep-
resented by discrete, dark bands on the gel where inhibition 
of MMP-induced degradation of the gelatin substrate had 
occurred. The TIMPs were identified by comparison with 
molecular weight markers and control standards of condi-
tioned medium containing mouse TIMP-1, -2, and -3 ex-
pressed by transfected BHK cells (University Technolo-
gies). 
Statistical Analyses 
Mean follicular diameters from the two experimental 
groups on Day 6 were compared using a 2-sample t-test. 
In addition, mean follicular growth rates from Days 0 to 6 
were compared within groups using the same test. Oocyte 
diameters from freshly isolated and cultured preantral fol-
licles were compared using a one-way ANOVA, with sub-
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FIG. 1. Growth of A) preantral and B) large preantral follicles in the 
presence (triangles) or absence (circles) of IGF-1 . Values are mean ± SEM. 
Growth is significant between Days 0 and 6 within both treatment groups 
(P< 0.01). 
groups. Oocyte diameters are also represented here graph-
ically using a box and whisker plot. The numbers of follic-
ular granulosa layers at the end of culture were compared 
between groups using a chi-square test. With probability 
estimates for the occurrence of MMPs and TIMPs. having 
been calculated, Baye's Theorem [23] was applied to esti-
mate the probability of granulosa or theca cell health given 
that MMPs and TIMPs were present. 
RESULTS 
Follicle Growth 
Follicles were cultured for 6 days in the presence (n = 
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FIG. 2. Box and whisker plot of histological measurements of mean oo-
cyte size on Days 0 and 6 of culture. n represents the total number ci 
follicles analyzed for each treatment. Box represents the median and the 
upper and lower quartiles. Whiskers illustrate the expected data range (* 
denotes outlier). Different letters indicate significant differences (P < 
0.01). 
being measured every second day. For analysis of growth, 
follicles were separated into two size classes: preantral 
(<150 m; n = 60), and large preantral (150-200 pm; n 
= 73). As Figure 1 illustrates, significant follicular growth 
occurred over 6 days in the presence and the absence of 
IGF-1 in both preantral and large preantral follicles (P < 
0.01). No significant effect of IGF- 1 on follicular growth 
was found in either size group (P > 0.05). 
Histological Assessment 
Histological observations were made using freshly iso-
lated follicles (n = 10), IGF- 1-treated follicles (n = 24), 
and control follicles (n = 22), all of which were 150-200 
pm before culture. A significant difference in oocyte di-
ameter between the three groups was detected by ANOVA 
(P < 0.01), and follicles treated with IGF-1 had signifi-
cantly smaller oocytes than controls and freshly isolated 
follicles (P < 0.01) (Fig. 2). Follicles cultured with IGF- 1 
also had a reduced number of granulosa cell layers (P < 
0.01) by Day 6 of culture (Table 1). However, IGF-1 had 
no effect on the percentage of follicles with degenerating 
oocytes and granulosa cells, the thickness and level of pyk-
nosis of the follicular theca cell layers, or the percentage 
of follicles that formed an early antrum in vitro (Table 1). 
Examples of follicles with healthy and degenerating so-
matic cells are shown in Figure 3. 
Secretion of MMP-2, MMP-9, TIMP- 1, and TIMP-2 
Activities 
Culture medium from 32 follicles was analyzed for ge-
latinase activity, and 24 samples were analyzed for 
TIMPs. Examples of a zymogram demonstrating MMP-2 
and MMP-9 activity and of a reverse zymogram showing 
TIMP- 1 and TIMP-2 secretion by follicles into the culture 
medium are shown in Figure 4. The MMP-2 (72 kDa) was 
released by 87.5% of follicles, whereas the MMP-9 (92 
kDa) was secreted by 62.5% of follicles (Fig. 4). Com-
parisons between zymographic analysis and morphology 
showed that if MMP-9 was secreted during culture, the 
probability of these follicles having healthy granulosa 
cells at the end of the culture period was 0.85. The prob-
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TABLE 1. Histological measurements of Day 6 of culture. 
Mean no. Oocyte Granulosa Theca 
Mean oocyte size granulosa layers Mean no. theca degeneration degeneration degeneration Antrum formation 
Treatment 	(i.m ± SEW (t SEM) layers (± SEMI (% follicles) (% follicles) (% follicles) (% follicles) 
Controlb 	 52.4 ± 3.60 9.3 ± 0.41 3.9 ± 0.53 18.2 18.2 47.4 40.1 
IGF-1' 37.8 ± 2.34i 6.4 - 	 030d 3.0 ± 0.44 37.5 16.7 58.8 33.3 
SEM = standard error of the mean. 
'n = 22. 
n = 24. 
d Significantly lower than control (P < 0.01) 
layers) was 0.60. When TIMP-1 (28 kDa) was released in 
vitro, (58% of follicles), the probability that the follicles 
would have healthy granulosa or theca cells was 0.79. 
When TIMP-2 (21 kDa) was produced (75% of follicles), 
the probability of the follicles having healthy granulosa or 
theca cells was 0.78 and 0.67, respectively. 
DISCUSSION 
The development of bovine preantral follicles to the ear -
ly antral stage in a serum-free culture system was achieved, 
and secretion of MMPs and lIMPs correlated with follic-
ular health during a 6-day period. We also demonstrated, 
to our knowledge for the first time, that IGF- I has a neg-
ative effect on oocyte size and granulosa cell proliferation 
during this early stage of follicular development. 
The IGF system has been well characterized in large 
antral follicles, but fewer studies have examined the effects 
of IGFs during earlier stages of follicular development. 
Wandji et al. [24] detected low IGF- I m.RNA levels in pri-
mary follicles from immature mice. but transcription in-
creased to a maximum during the late preantral and early 





. 	9. 	. 
-  
els of IGF-l. This indicates that IGF-1 is associated with 
the growth and survival of rapidly expanding, large prean-
tral and early antral follicles in the mouse [24, 251. How-
ever, differences in the temporal and spatial production of 
IGF- I between rodents and domestic species suggests dif-
ferent mechanisms of action. In sheep, the influence of IGF-
1 on granulosa cells from small (1-3 mm) sheep follicles 
is proliferative, whereas in more mature follicles (5-7 mm), 
steroidogenic effects predominate [26]. Regarding the 
source of IGF- 1, mRNA has been detected during the early 
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FIG. 4. Representative 	 . 	A . 	 'Tiogran 
FIG. 3. F-tistrilogical sections representing A a follicle with a h(- ,alth' 	showing gelatinase (MMP) and lIMP activities secreted in samples ofcul- 
oocyte 0), even granulosa cells tgi with spacing that may indicate an ture medium. The MMP-2 and MMP-9 orTIMP-1 and TIMP-2 presence is 
early antrum (ea), and a differentiated theca layer (t); and B a follicle 	indicated in four follicles with granulosa cells (GC) that are healthy (H) 
with pyknotic granulosa cells (p) and degenerated theca cells. Bar = 50 or degenerate (D) and theca cells (TC) that are healthy (H) or degenerate 
p.m. 	 (D). 
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antral stage in both granulosa and theca cells of sheep fol-
licles [271 and in granulosa cells of porcine follicles [28], 
but no IGF-1 expression has been found during the prean-
tral stage. In cattle. IGF- 1 mRNA has been detected at low 
levels in granulosa cells of antral follicles, with an in-
creased level after selection [29], and also in theca cells 
[30], indicating that IGF-1 may be important during the 
later stages of folliculogenesis (e.g., in relation to LH re-
sponsiveness). 
Although IGF- 1 attenuates spontaneous apoptosis in por-
cine granulosa cell cultures [31], it is not produced by ovine 
or bovine granulosa cells in vitro in the absence of lutein-
ization [32, 33]. Receptors for IGF-1 on bovine granulosa 
cells do not fully develop until the antral stage [34], and 
this indicates a paracrine rather than an autocrine role for 
IGF- 1 in the control of granulosa cell function, with IGF-
I playing a role later in the follicular cycle among domestic 
species than among rodents. Therefore, any positive effects 
on follicular development should be limited, which we have 
confirmed in the present study. Previously, Gutierrez et al. 
[11] reported that IGF-1 had a stimulatory effect on follic-
ular and oocyte growth and antrum formation in an ex-
tended culture using confocal microscopy. They did not, 
however, present any data on follicular health. In addition, 
their study had limitations regarding the detection of an 
early antral cavity or early signs of atresia. Therefore, in 
the present study, we used histological analysis and a short-
er culture period to detect the effects of IGF-1 during the 
early stages of development in more detail. A longer culture 
period may allow granulosa cells to differentiate sufficient-
ly for IGF- 1 to function as a stimulator of development, as 
reported by Gutierrez et al. [11]. Thus, the present study is 
novel, in that its results suggest the action of IGF-1 is strict-
ly regulated according to developmental stage, and that 
treatment of immature follicles with IGF-1 may result in 
precocious differentiation, retarding growth and prolifera-
tion. 
Regarding the preantral and early antral stages of fol-
licular development, very little is known concerning the 
contribution of the various MMPs and associated regula-
tors to follicular remodeling. We demonstrated that when 
MMP-9 and TIMPs are secreted in vitro, a follicle has a 
higher probability of being healthy at the end of the cul-
ture period. Several studies have investigated the distri-
bution of MMPs and TIMPs at different stages of follic-
ular development. In the ovary of neonatal rats, activity 
of MMP-2, but not MMP-9, has been detected, with vi-
sualization of TIMP-1 in the oocyte [20]. In eCG-primed 
ovaries of rats and mice, MMP-2 is detected in the gran-
ulosa and theca cells, MMP-9 is restricted to thecal and 
interstitial cells, and TIMP-1 is located in the blood ves-
sels and theca cells [20, 35, 36]. In addition. MMP-9 is 
restricted to the theca cells layers in goat follicles of less 
than 3 mm [37], and it has been detected in the differen-
tiating granulosa cells in culture [18] and, subsequently, 
in the developing corpus luteum of rats [20]. Collectively, 
the results of these studies implicate the granulosa and 
theca cells as sources of MMPs and TIMPs during the 
follicular stage of development. 
In vitro, secretion of MMP-2 and MMP-9 from bovine 
thecal cells increases in response to LH [17]. This obser-
vation may imply that theca cells have a role in remodeling 
of the basement membrane, or that the remodeling of vas-
cular tissue present within the culture may be under go-
nadotropin control. The regulation of MMP activity is com-
plex and may be controlled at the level of transcription by  
growth factors, cytokines, and hormones, with subsequen 
activation of secreted proforms and inhibition by TIMP 
[36]. The mechanisms controlling remodeling at the gonad 
otropin -independent stages of follicular development an 
unknown: thus, further investigations are required. Thi 
MMPs and TIMPs also may be regulated depending oi 
their specific spatial and temporal functions. The distribu 
tion of MMP-9 in the steroidogenic cells of the theca laye 
[20], interstitium. and corpus luteum as well as its abseno 
in the neonatal ovary [20] and the timing of expression [38 
suggest a role in the remodeling and vascularization asso 
ciated with corpus luteum formation. The detection o 
MMP-2 and MMP-9 during our study in cattle suggests 
47 role for these enzymes at a much earlier stage than, to ou 
knowledge, has been studied previously, and that MMP- 1. 
 TIMPs can now be used as noninvasive markers fo 
assessing follicular quality in vitro. 
The TIMPs have been implicated in other processes in 
volving cell growth. For example. TIMP-1 has been as 
sociated with erythroid-potentiating activity [39] an 
TIMP-1 and -2 have growth factor-like activities in somi 
cell types [40]. The increased probability of follicula 
health when TIMPs were present in our study agrees wit] 
this function. Results of other reports suggest that TIMP 
1 is a facilitator of steroidogenesis [41-43]. Difference 
in TIMP activity between atretic and nonatretic follicle 
during the late preantral and early antral stage may be 
marker for the shift in steroidogenic capability and futur 
selection of healthy follicles at this stage of development 
The significance of the location of TIMP-1 in the oocyt 
[20] is unclear, and during the early stages of folliculo 
genesis, a potential function for TIMPs as oocyte growt] 
factors remains uninvestigated. Future experiments shouli 
assess if the correlation between MMP and TIMP secre 
tion with follicular quality in vitro also applies to oocyt 
health and development. This will allow us to better un 
derstand interactions between the oocyte and somatic cell: 
regarding the coordination of oogenesis and folliculoge 
nesis. 
In our study, follicles that did not maintain a differen 
tiated thecal layer in vitro tended to be less healthy overal 
than follicles with thick, nonpyknotic theca cell layers 
Maintaining interplay between the oocyte and the sur 
rounding somatic cells is vital to achieve normal follicu 
logenesis. Growth differentiation factor-9 (GDF-9), whicl 
is an oocyte-derived factor from the transforming growtl 
factor-p superfamily, is required for sustaining follicula 
growth and differentiation after the primary (i.e., one-lay 
er) follicular stage [441. Studies using knockout mice [44 
45] have shown that in the absence of GDF-9, follicle 
are incompetent to emit a signal that recruits theca cel 
precursors to surround the basement membrane [45]. Ou 
observations confirm the importance of maintainin 
healthy theca cells and their connections with the granu 
losa layers in bovine follicular culture, and our observa 
tions also support a role for these cell types in basemen 
membrane remodeling during the early stages of follicu 
logenesis. 
In conclusion, we have reported bovine follicular de 
velopment from the preantral to the antral stage in a se 
rum-free culture system. Use of IGF-1 as a treatment ha( 
no positive effects on follicular development during th 
preantral and early antral stages. We detected MMP am 
TIMP activity in vitro and identified MMP-9, TIMP-1, am 
TIMP-2 as markers of follicular health. Elucidation re 
garding the action of MMPs and TIMPs and the role o 
72 
	
McCAFFERY ET AL. 
rowth factors during follicle growth and antrum forma-
ion in an extended culture will provide insight into the 
:omplex processes involved in follicular and oocyte 
rowth and development. Improving our knowledge of the 
nteractions between follicular cells and the extracellular 
natrix is necessary for maintaining the integrity of prean-
ral follicles in vitro, thus sustaining follicular growth and 
'iability. 
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